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TO AVIAN INFECTIOUS BRONCHITIS VIRUS (IBV)
by Juan Carlos Lopez
The first aim of this research was to determine the prevalence of IBV in broilers within the
Canterbury province, New Zealand, in late winter and to search for associations with
management or environmental factors. The second aim was to study how ambient stressors
affect the immune system in birds, their adaptive capacity to respond, and the price that they
have to pay in order to return to homeostasis.
In a case control study, binary logistic regression analyses were used to seek associations
between the presence of IBV in broilers and various risk factors that had been linked in other
studies to the presence of different avian pathogens: ambient ammonia, oxygen, carbon
dioxide, humidity and litter humidity. Pairs of sheds were selected from ten large broiler
farms in Canterbury. One shed (case) from each pair contained poultry that had a production
or health alteration that suggested the presence of IBV and the other was a control shed.
Overall, IBV was detected by RT-PCR in 50% of the farms. In 2 of the 5 positive farms (but
none of the control sheds) where IBV was detected there were accompanying clinical signs
that suggested infectious bronchitis (IB). Ambient humidity was the only risk factor that
showed an association (inverse) with the prevalence of IBV (p = 0.05; OR = 0.92). It was
concluded within the constraints of the totally enclosed management systems described, that
humidity had an influence on the presence of IBV, but temperature, ammonia, carbon dioxide,
oxygen or litter humidity had no effect.
iii
In another study environmental temperatures were changed in order to affect the biological
function and adaptive capacity of chickens following infection with IBV. The ‘affective
states’ of the animal were assessed by measuring levels of corticosterone (CORT) in plasma
and tonic immobility (TI). It was found that low (10 +/- 2
o
C) and high (30 +/- 2
o
C)
temperatures exacerbated the respiratory signs and lesions in birds infected with IBV as
compared to those housed at moderate (20 +/- 2
o
C) temperatures. The chickens housed at high
temperatures showed significantly decreased growth, a higher proportion of hepatic lesions
(principally haemorrhages) and a longer tonic immobility period, but there was no significant
alteration in the plasma levels of CORT. The birds housed at low temperatures developed a
higher proportion of heart lesions (hydropericardium, ventricular hypertrophy) and had
significantly higher levels of plasma CORT than birds housed under moderate and/or high
temperatures. The specific antibody response to IBV decreased in birds housed under high
temperatures. Interestingly the birds housed at high temperatures developed significantly
higher levels of haemagglutinin antibodies to sheep red blood cells (SRBC) than those birds
housed under low or moderated temperatures. Cell mediated immunity was not significantly
affected by heat or cold stress in the first 13 days of treatment but at 20 days the levels of
interferon gamma in the birds subjected to low temperatures were lower than in the high
temperature group.
In other trials, the exogenous administration of low physiological doses of oral CORT (as
compared to high pharmacological doses typically used in such experiments) to birds resulted
in suppression or enhancement of the immune response depending on duration of treatment
and/or dose and nature of the antigen. To our knowledge, this is the first study to show that
exogenous CORT can produce an enhancement in the immune response in chickens.
iv
In conclusion, environmental stressors such as high or low temperatures do affect the
physiology of the fast-growing broiler. The adjustments the birds have to make to maintain
homeostasis impacts on the course of common infectious diseases, such as IB, that normally
is mild in the New Zealand poultry industry. The administration of exogenous CORT showed
that this hormone may be part of the physiological stress response and acts as a messenger to
prepare the immune system for potential challenges (e.g., infection).
vAcknowledgements
I would like to acknowledge the advice, guidance, patience and friendship of Dr Robin
McFarlane. I doubt that I will ever be able to express my appreciation fully, but I owe him my
eternal gratitude. I would like to thank my co-supervisor Dr Graham Barrell for his valuable
suggestions.
Special thanks go to Martin Wellby, Omega Amoafo, Janette Busch and Karl Gately - without
whose knowledge and assistance this study would not have been successful.
Thanks to NZAID for the scholarship and Tegel Foods Ltd for their collaboration and
support. I would like to thank Alison Lister for assistance with the statistical analysis.
Finally, I would like to thank my family, especially my wife Adriana, for support and help
with my experiments. Without her help and encouragement, I would not have finished my
PhD.
vi
List of Contents
Abstract ii
Acknowledgments v
List of contents vi
List of tables xi
List of figures xiii
Abbreviations xvi
Chapter 1 Introduction 1
Chapter 2 Literature review 5
2.1 Seasonal cycles of infectious diseases 5
2.2 Welfare and stress in poultry 5
2.2.1 Mechanisms of the general adaptation syndrome (GAS) 7
2.2.2 Hypothalamo-pituitary-adrenal axis (HPA) 8
2.3 Body temperature and avian thermoregulation 10
2.3.1 Physiological changes due to effect of heat or cold 11
2.3.2 Effect of temperature on the immune system in birds 12
2.4 Infectious bronchitis 13
2.4.1 IB in New Zealand 14
2.4.2 Aetiology 15
2.4.3 Strain classification 15
2.4.4 Transmission and carriers 17
2.4.5 Clinical signs 17
2.4.6 Pathogenesis 18
2.4.7 Lesions 19
2.4.8 Diagnosis 20
vii
2.4.9 Treatment 22
2.5 Poultry immune system 22
2.5.1 Immune response against IBV 23
2.5.1.1 Innate immunity 23
2.5.1.2 Humoral immunity 23
2.5.1.3 Cellular immunity 25
2.5.1.4 Passive immunity 26
2.5.2 Vaccination against IBV 26
2.5.2.1 Types of vaccines 26
2.5.2.2 Vaccination programs 27
Chapter 3 The influence of environmental factors on the prevalence
of infectious bronchitis 30
3.1 Introduction 30
3.2 Materials and methods 31
3.2.1 Farms 31
3.2.2 Clinical signs and detection of IBV 32
3.2.3 Ambient measurements 34
3.2.4 Questionnaire and data analysis 34
3.3 Results 34
3.4 Discussion 36
viii
Chapter 4 Effect of thermal change on immune responses and physiological
function in chickens 40
4.1 Introduction 40
4.2 Materials and methods 42
4.2.1 Animals and housing conditions 42
4.2.2 Immunization 43
4.2.3 Blood sampling 45
4.2.4 Clinical signs 45
4.2.5 Lesions and mortality 46
4.2.6 Body weights, haematocrit and body temperature 47
4.2.7 Tonic immobility (TI) 47
4.2.8 Corticosterone 47
4.2.9 Antibody 47
4.2.10 Interferon gamma 48
4.2.11 Statistical analysis 49
4.3 Results 49
4.3.1 Clinical signs 49
4.3.2 Lesions and mortality 51
4.3.3 Weight gain, haematocrit and body temperature 53
4.3.4 Tonic immobility and plasma corticosterone levels 53
4.3.5 Humoral immune response 55
4.3.6 Cell mediated immune response 57
4.4. Discussion 58
ix
Chapter 5 Effect of corticosterone on the immune response
in broiler chickens 64
5.1 Introduction 64
5.2 Materials and methods 66
5.2.1 Titration of oral corticosterone treatment 66
5.2.2 Animals, housing conditions and corticosterone treatment 67
5.2.3 Infection and immunization 68
5.2.4 Clinical signs 69
5.2.5 Lesions 69
5.2.6 Relative spleen weights 69
5.2.7 Tonic immobility (TI) 69
5.2.8 Plasma corticosterone 70
5.2.9 Determination of antibody titres 70
5.2.10 Interferon gamma 70
5.2.11 Intradermal hypersensitivity 70
5.2.12 Statistical analysis 71
5.3 Results 71
5.3.1 Dose effect of corticosterone (pilot trial) 71
5.3.2 Clinical signs 72
5.3.3 Lesions 73
5.3.4 Body weight and relative spleen weights 74
5.3.5 Tonic immobility and plasma CORT levels 75
5.3.6 Humoral immune response 76
5.3.7 Cell mediated immune response 77
5.4 Discussion 79
xChapter 6 Effects of corticosterone on the immune response in chickens
depend on duration of action 84
6.1 Introduction 84
6.2 Material and methods 85
6.2.1 Animal and housing conditions 85
6.2.2 Experimental infection, immunization and blood sampling 86
6.2.3 Clinical signs and lesions 87
6.2.4 Tonic immobility (TI) 88
6.2.5 Corticosterone levels in drinking water and plasma 88
6.2.6 Determination of antibody titres 88
6.2.7 Interferon gamma (IFN γ) 88
6.2.8 Statistical analysis 88
6.3 Results 89
6.3.1 Clinical signs and lesions 89
6.3.2 Body and spleen weights 90
6.3.3 Tonic immobility and CORT levels 92
6.3.4 Humoral immune response 93
6.3.5 Cell mediated immune response 94
6.4 Discussion 97
Chapter 7 General discussion 102
References 110
Appendices 136
xi
List of Tables
Table 3.1. Logistic regression analysis of factors associated with the
presence of IBV in broiler farms 35
Table 4.1. Confidence intervals for mean body weigh haematocrit and body
temperature of birds housed under high (H), moderate (M)
or low (L) temperatures 53
Table 4.2. Confidence intervals for mean CORT levels in plasma from birds
housed under high (H), moderate (M) or low (L) temperatures 55
Table 4.3. Confidence intervals for IBV and hemagglutinin titres of
birds housed under high (H), moderate (M) or low (L) temperatures 56
Table 4.4. Confidence intervals for interferon gamma levels of birds housed
under high (H), moderate (M) or low (L) temperature 57
Table 5.1. Statistical differences between relative spleen
weights (grams) (42 days of age), determined by LSD 74
Table 5.2. Statistical differences between the means of TI (41 days of age) 75
Table 5.3. Statistical differences between the increase of antibody
titres to IBV (day 27 to 42 of age), as determined by LSD 76
Table 5.4. Statistical differences between the means of haemagglutinin
titres to SRBC (eight days post challenge), as determined by LSD 77
Table 5.5. Statistical differences between the mean levels of interferon gamma
released from spleen cells stimulated with IBV antigen and measured by
ELISA (8 and 15 days post challenge), as determined by LSD 78
Table 5.6. Statistical differences between the means of the PHA reaction (mm),
as determined by LSD 79
Table 6.1. Body and spleen weights from birds untreated with CORT but
challenged with IBV (IBV), treated with CORT from day 23 but not challenged
with IBV (CORT 23), treated with CORT from day 26 of age and challenged
with IBV (IBV+CORT 26), and birds treated with CORT from day 23 and
challenged with IBV (IBV+CORT 23) 91
Table 6.2 The skin reaction produced by the intradermal injection of PHA
in birds from groups treated with CORT 2 days pre challenge
(IBV+CORT 26), 5 days pre challenge (IBV+CORT 23), and not treated
with CORT (IBV) 96
xii
Table 6.3. Summary of the effects of CORT on the immune respone in chickens
treated with CORT from 2 days before challenge with IBV and injected with
SRBC (CORT 26 IBV), treated with CORT from 5 days before challenge with
IBV and injected withSRBC (CORT 23 IBV), treated with CORT at 23 days of
age but without challenge with IBV or injected with SRBC (CORT), and birds
not treated with CORT but challenged with IBV and injected with SRBC (IBV) 97
xiii
List of Figures
Figure 31. RT-PCR amplimers using the primers NT1 and NT2 35
Figure 4.1. Experimental design to test the effect of thermal change on immune
responses and physiological function in chickens 43
Figure 4.2.Mitogenic response of chicken splenocytes to Con A 44
Figure 4.3. Relationship between recall antigen and cell concentrations 45
Figure 4.4.Mean clinical score (0-3) of birds housed under high (■),
moderate (●), or low temperature (■) 50
Figure 4.5. (a) Bird under high temperature with its neck extended,
(b) birds under low temperature crowded together 50
Figure 4.6.Mean lesion (air sac) score of birds housed under different
temperatures 51
Figure 4.7.Mean lesion (liver) score of birds housed under different
temperatures 51
Figure 4.8. Liver haemorrhages found in bird housed under high temperature 52
Figure 4.9. Hydropericardium in bird housed under low temperature 52
Figure 4.10. Bird in a U-shaped cradle during the TI test 54
Figure 4.11.Mean plasma corticosterone concentrations of birds housed
under high (■), moderate (●), or low temperature (■) 54
Figure 4.12. Antibody titre to IBV measured by ELISA from chickens housed
under high (■), moderate (●), or low temperature (■) 55
Figure 4.13. Haemagglutinin titre to SRBC of birds housed under
high (■), moderate (●), or low temperature (■) 56
Figure 4.14. Levels of interferon gamma from chickens housed under high (■),
moderate (●), or low temperature (■) 57
Figure 5.1. Experimental design to test the effect of corticosterone on the
immune response in broiler chickens 68
Figure 5.2. Plasma CORT concentrations in chickens untreated (♦)
or treated with CORT at 15.4 mg/l (■) or 7.7 mg/l (□) 71
Figure 5.3. Haemagglutinin titre to SRBC measured in birds treated
with 15.4 mg/l of CORT (■), 7.7 mg/l of CORT (□) or untreated (♦) 72
xiv
Figure 5.4.Mean clinical score (0-3) of birds under CORT treatment
and challenged with IBV (■), untreated with CORT and challenged
with IBV (▲), and control (untreated with CORT and no challenge) (○) 72
Figure 5.5. (a) Fatty and enlarged liver from a bird under CORT treatment,
(b) liver from an untreated bird 73
Figure 5.6. Large accumulation of fat in the abdominal cavity
of a CORT-treated bird 73
Figure 5.7. (a) Spleen from an untreated bird, (b) spleen from
a bird treated with CORT for 22 days 74
Figure 5.8.Mean plasma levels of CORT from chickens treated
with CORT and challenged (■), untreated with CORT but challenged with
IBV (▲), and controls (○) untreated with CORT and not challenged with IBV 75
Figure 5.9. Antibody titre to IBV, measured by ELISA, from chickens
challenged with IBV and treated with CORT (■), or untreated with
CORT (▲), and controls, not challenged with IBV (○) or treated with CORT 76
Figure 5.10. Haemagglutinin titres to SRBC measured in birds under CORT
treatment and injected with SRBC (■), not treated with CORT and injected
with SRBC (▲), and controls (○) neither treated with CORT nor SRBC 77
Figure 5.11. Levels of IFNγ released from spleen cells stimulated with
IBV antigen and measured by ELISA, from chickens treated with CORT (■),
untreated with CORT (▲), and controls (○) neither treated with IBV nor CORT 78
Figure 5.12. Reaction to PHA injection (right wattle) of birds not treated
with CORT (a, b), as compared to a bird treated with CORT (c) 79
Figure 6.1. Experimental design to test the effects of corticosterone on the
immune response in chickens 87
Figure 6.2.Mean clinical score (0-3) of birds under CORT treatment for
two days before challenge with IBV (▲), treated with CORT for 5 days
before challenge with IBV (■), and not treated with CORT (○) 89
Figure 6.3. Liver with several haemorrhages found in bird under CORT
treatment from 23 days of age. 90
Figure 6.4. Plasma CORT concentration in chickens following CORT
treatment from 26 days of age and challenged with IBV (▲), treated with CORT
from 23 days of age and challenged with IBV (■), treated with CORT from 23
days of age but not challenged with IBV (○) and birds not treated with CORT
but challenged with IBV (●) 92
xv
Figure 6.5. Antibody titre to IBV (ELISA) in chickens following CORT
treatment from 26 days of age and challenged with IBV (▲), treated with CORT
from 23 days of age and challenged with IBV (■), treated with CORT from 23 days of
age but not challenged with IBV (○) and birds not treated with CORT but
challenged with IBV (●) 93
Figure 6.6. Haemagglutinin titre to SRBC measured in chickens treated with
CORT from 2 days before injection with SRBC (at 28 days of age) (▲), treated
with CORT from 5 days before injection with SRBC (■), treated with CORT
from 23 days of age but without injection with SRBC (○) and birds not treated
with CORT but with injection with SRBC (●) 94
Figure 6.7. Levels of interferon gamma released from spleen cells stimulated
with IBV antigen and measured by ELISA in chickens treated with CORT from
two days before challenge with IBV (▲), treated with CORT from 5 days
before challenge with IBV (■), treated with CORT from 23 days of age but not
challenged with IBV (○) and not treated with CORT but challenged
with IBV (●) 95
xvi
Abbreviations
ACTH Adrenocorticotropic hormone
AGPT Agar gel precipitation test
ASC Antibody secreting cells
AVT Arginine vasotocin
CKC Chicken kidney cells
CI Confidence interval
CMI Cell mediated immunity
ConA Concanavalin A
CORT Corticosterone
CRF Corticotropin releasing factor
CTL Cytotoxic T lymphocyte
ELISA Enzyme linked immunosorbent assay
FAO Food and Agriculture Organization of the United Nations
GAS General adaptation syndrome
GC Glucocorticoid
HI Haemagglutination inhibition
HPA Hypothalamo pituitary adrenal axis
IB Infectious bronchitis
IBV Infectious bronchitis virus
IFA Immunofluorescence assay
IL Interleukin
INF Interferon
IPA Immunoperoxidase assay
KLH Keyhole limpet haemocyanin
MAF Ministry of Agriculture and Forestry
MDA Maternal derived antibody
xvii
MG Mycoplasma gallisepticum
MHC Major histocompatibility complex
NK Natural Killer
OR Odds ratio
OIE Office International des Epizooties
PCR Polymerase chain reaction
PCV Packed cell volume
PHA Phytohaemagglutinin
PHS Pulmonary hypertension syndrome
rChIFN Recombinant chicken interferon
RIA Radioimmunoasaay
RNA Ribonucleic acid
RT-PCR Reverse transcriptase polymerase chain reaction
RVH Right ventricular hypertrophy
SEM Standard error of the mean
SRBC Sheep red blood cells
TI Tonic immobility
TM Transport media
TNF Tumour necrosis factor
VI Virus isolation
VN Virus neutralisation
1Chapter 1
THE EFFECT OF ENVIRONMENTAL STRESSORS ON THE IMMUNE RESPONSE
TO AVIAN INFECTIOUS BRONCHITIS VIRUS (IBV)
INTRODUCTION
The importance of poultry production has increased during recent decades and will increase in
the future due to the rise in demand for food, together with human population growth. Almost
every country in the world has a poultry industry of some kind. According to the Food and
Agriculture Organization of the United Nations (FAO) poultry meat is ranked as the second
major source of protein for the world’s population behind pork. In many countries poultry is
the meat with the highest per capita consumption (e.g., USA, New Zealand).
The FAO predicted a 2.9 percent per year increase in demand for poultry meat around the
world until the end of 2015, against a 1.4 annual percent increase in demand annually for
beef. Although the poultry industry is relatively new in New Zealand, it has been expanding
rapidly. According to the Poultry Industry Association of New Zealand, in 2004, the poultry
industry produced more than 87.5 million broiler chickens, weighing 151,497 tonnes. Poultry
meat annual consumption continues to increase in New Zealand, up from 14 kg per capita in
1986, to 37.10 kg per capita in 2006. In addition, New Zealand currently has 2.7-2.8 million
laying hens that produce around 816-880 million eggs.
Despite progress that has been made in the areas of health, vaccine use and management in
the poultry industry, problem diseases still exist that affect the efficiency of the poultry
industry. Seasonal cycles of infectious diseases have been variously attributed to changes in
environmental conditions, the prevalence or virulence of the pathogen, or the behaviour of the
host, but no single theory has proved a satisfactory explanation (Dowell 2001). Avian
infectious bronchitis virus (IBV) is a major respiratory virus of chickens, as it is probably
2endemic in all countries that raise chickens (Cavanagh and Naqi 2003). Diseases caused by
coronaviruses such as IBV are more frequent in winter, with a unique ability to establish
persistent infections in a minority of infected animals (Holmes 2003; Dowell and Ho 2004).
In the majority of the more affluent countries, broilers are reared intensively in
environmentally controlled sheds, without cages, and feed and water are available ad libitum.
However, some farmers in developed countries have returned to old fashioned ‘free range
chicken’ rearing methods because of demands from a sector of consumers with a desire for
natural or organic food products (Darre 2003). Under such farming systems the birds face
pressure from different pathogens and, simultaneously, undergo various kinds of physical,
climatic and social stresses (Hangalapura et al 2003; Van Loon et al 2004) of a different type
from those experienced in intensive housing.
In New Zealand farmers use broiler chicken populations that have been genetically selected
for rapid growth. These modern breeds of chickens have been bred for confined conditions
and require precise environmental control to achieve maximum performance (Darre 2003).
Studies comparing the red jungle fowl (one predecessor of modern poultry breeds) to
commercial layer and broiler chickens have documented the reduced respiratory capacity of
the fast-growing chicken (Vidyadaran et al 1987).
The study of animal welfare continues to struggle with two persistent problems: how to define
animal welfare and how to determine which measures should be used to evaluate welfare
(Mench 2000). One common indicator used for the determination of animal welfare is the
presence of stress. The perception of the general public is that any management or condition
that causes stress for the animals should be avoided or prohibited. One scientific point of
view, however, is that stress endangers the animal’s welfare only if it results in some
significant biological change that places that animal’s health at risk (Moberg 2000). The term
3‘distress’ has been used by some researchers in order to differentiate between a non-
threatening stress response (‘good stress’) and the biological stage where the response has a
deleterious effect on the animal’s welfare. Measurements of immune competence offer us a
potentially powerful tool for evaluating the results of distress and for differentiating between
stress and distress situations (Moberg 2000). It is widely assumed that the negative economic
impact of disease is enhanced in distressed animals (Dohms and Metz 1991), and this may be
mediated via a neuroendocrine response that affects the normal performance of the immune
organs (El-Lethey et al 2003).
Some factors are believed to intensify the clinical signs and lesions present in various diseases
or affect the immune response in poultry: low or high environmental temperatures (Regnier
and Kelly 1981; Ratanasethakul and Cumming 1983; Henken et al 1983; Hangalapura et al
2003; Hangalapura et al 2004a) high ammonia levels (Anderson et al 1964; Kling and Quarles
1974), low levels of oxygen (Olander et al 1967) and circulating corticosterone levels (El-
Lethey et al 2003). Supporting evidence from studies that have been trying to explain the
effect of stress on the avian immune system are based, to a large extent, on the use of non-
natural stress models (El-Lethey et al 2003). Moreover, in the majority of these studies, the
humoral response to a single antigen or pathogen was considered, but the impact of stress
upon cell-mediated immunity has not been addressed (El-Lethey et al 2003). Only some of
these factors have been studied in relation to immunity following an IBV infection. Welfare is
a complex phenomenon and only a multifactorial approach, including physical health,
production traits and physiological and behavioural indicators, can allow a relevant
assessment (Neindre et al 2004).
4The first aim of this research was to determine the prevalence of IBV in broilers within the
Canterbury province in late winter and search for associations with managemental or
environmental factors. The second aim of this research was to study how ambient stressors
affect the immune system and adaptive capacity of broilers.
5Chapter 2
LITERATURE REVIEW
2.1 Seasonal cycles of infectious diseases
Disease is the result of complex interactions (some would say imbalance) between the triad of
the agent (toxic or infectious), the host and the environment (Campbell et al 1983). Many
diseases show a regular and predictable pattern of seasonality. Different infections peak in
each of the four seasons, but each pathogen and the timing and characteristics of the annual
outbreak are remarkably consistent from year to year (Dowell 2001). Diseases caused by
coronaviruses such as IBV, show winter seasonality (Holmes 2003). The origin of this
seasonality is not clear. It can be attributed to environmental changes, changes in host
physiology or alterations in the virus (Dowell 2001). Ramneek et al (2005) showed that the
sequences of the S1 gene isolated from historic and new field isolates of IBV in New Zealand
had a high homology indicating very little season to season change. Seasonal changes in host
physiology are controlled principally by the duration of the night/dark cycle and mediated by
changes in the daily melatonin pulse (Dowell 2001). The majority of the poultry sheds in New
Zealand are closed, with a similar light/dark programme throughout the whole year. Hence it
is expected that only ‘free range’ poultry would be affected by such mechanisms.
2.2 Welfare and stress in poultry
Since the controversy generated by Harrison (1964) with the publication of her book Animal
Machines: The New Factory Farming Industry, there has been an enormous debate over what
exactly animal welfare is and how it should be assessed. Duncan and Dawkins (1983) and
Broom (1986) reviewed the definitions of welfare that various investigators had proposed and
concluded that it is impossible to give welfare a precise scientific definition and that the best
that can be achieved is a broad working description encircling the ideas of the animal’s
6physical and mental health; the animal being able to adapt to its environment without
suffering. Diseases are a major and persistent factor in animal suffering, and combating them
must be a priority for all those seeking to improve animal welfare [Office International des
Epizooties (OIE) 2005].
Society has divergent views with regard to how animal welfare should be assessed (Wyss et al
2004). In general, there are three different ways that welfare has been measured: ‘biological
functioning’, ‘affective states’ and ‘natural living’ (Fraser 2004). According to ‘biological
functioning’, good animal welfare is characterised by a high level of health, growth,
production efficiency and correlated traits (Fraser 2004). According to the second point of
view, animal welfare should focus on the way the animal perceives its environment in terms
of emotions (such as fear and pain) which is the ultimate goal of the assessment (‘affective
states’) (Neindre et al 2004). Duncan et al (1986) used the tonic immobility test in chickens in
order to assess animal welfare from the ‘affective states’ point of view. They found that the
mechanical harvester system produced less fear in the chickens than the traditional manual
catching system. The third position ‘natural living’ believes that animals should be allowed to
lead reasonably natural lives by carrying out their normal behaviour, free from restraint. The
majority of current welfare audit schemes (e.g., www.biosecurity.govt.nz/animal-welfare) are
based on standards set around prescribing the resources available to the bird, such as litter
type or ventilation system capacity ‘input measures’. Many authors consider that input
measures are much less reliable as welfare assessment measures than ‘output’ measures; that
is, those based on the ‘experience’ of the bird (Moberg 2000).
Each of these viewpoints make valid claims and attracts valid criticism (Fraser 2004). One
common indicator used for the determination of animal welfare is the presence of stress.
Fraser et al (1975) defined stress in a veterinary context as ‘an abnormal or extreme
7adjustment in the physiology of the animal to cope with adverse effects in its environment and
management’.
Since the times of Hippocrates (460-375 BC) it has been postulated that for the correct
function of the body (health) it has to be in ‘balance,’ and when there are alterations in that
balance ‘disharmony’ or disease occurs (Chrousos et al 1988). Stress is only negative when it
adversely affects the animal’s welfare, when it may be termed ‘distress’ (Moberg 2000). An
important characteristic of stress is its duration and magnitude. It has been reported that mild
or brief stress (minutes to hours) may enhance the cell mediated (Blecha et al 1982), humoral
(Solomon 1969), and innate (Deak et al 1997) immune responses. The benefit to the host of
these physiological responses is not clear, but it has been suggested that altered recirculation
patterns represent a realignment of cellular duties from ‘patrol’ to ‘battle stations’ in response
to an anticipated immunological challenge that would accompany injury. In contrast, severe
stress has been shown to suppress various immune parameters (Subba Rao and Glick 1970;
Ader et al 2001; El-Lethey et al 2003).
2.2.1 Mechanisms of the general adaptation syndrome (GAS)
Selye (1949) believed that animals must respond to changing environmental conditions in
order to maintain homeostasis, using a non-specific stress response pathway, the GAS.
Animals, after initial perception of an attack, harm or threat to their survival, mount an
emergency ‘alarm’ phase or fight-flight response (Cannon 1914; 1932). These catecholamine-
driven reactions result in increased cardiovascular function and an overall increase in
metabolism. The animals need all the energy that they can afford for fight, or if the predator is
‘too big', flight. If the stressor persists, the ‘resistance’ phase is initiated, which is a
physiological coping reaction and eventually an ‘exhaustion’ phase may develop leading to
pathology (Selye 1949; 1976; Cannon 1932; Moberg 1985). These responses may be
8quantified by measurement of glucocorticoids. These hormones are released when the
hypothalamo-pituitary-adrenal axis (HPA) is activated in response to a stress situation.
However, many researchers believe that the GAS theory is too simplistic (Dohms and Metz
1991) as not all animals under stress produce glucocorticoids (Moberg 1985). The response
may or may not differ between stressors (El-Lethey et al 2003). For example, stallions
secreted similar amounts of cortisol whether they were restrained, exercised or mated with
mares (Colborn et al 1991).
2.2.2 Hypothalamo-pituitary-adrenal axis (HPA) 
In birds, the HPA axis is well characterized (Holmes 1978; Harvey and Hall 1990). When a
stressor is perceived hypothalamic corticotropin-releasing factor (CRF) and arginine
vasotocin (AVT) are secreted, which stimulate the anterior pituitary gland to secrete
adrenocorticotropic hormone (ACTH) (Kovacs and Peczely 1991). Circulating ACTH levels
peak within 5-10 minutes of the stress (Kovacs and Peczely 1991). The release of ACTH is
antagonized by hypothalamic somatostatin (SRIF) (Cheung et al 1988). Circulating ACTH in
turn causes the adrenal cortex to produce glucocorticoids (GC) within 5 minutes, and in a
dose-dependent manner (Radke et al 1985; Beuving and Vonder 1986). Chickens treated with
ACTH (50 IU/animal) show an increase of plasma corticosterone (CORT) (the principal
corticosteroid) to about 25ng/ml within 1h, followed by a drop to pre-treatment levels after 4h
(Assenmacher 1973; Dehnhard et al 2003). Basal levels of CORT in one-week-old domestic
chicks are approximately 11-23 ng/ml across various domestic fowl strains (Carsia and Weber
1986; Decuypere et al 1989) with basal levels decreasing as a function of age: 5-7 ng/ml in 3
weeks old commercial broilers (Post et al 2003) and to 0.42- 6.04 ng/ml in 51 week old laying
hens (Littin and Cockrem 2001). In chickens, most circulating corticosterone is transported
bound in dynamic equilibrium to plasma proteins (Carsia and Harvey 2000). Alterations in the
9corticosterone levels in response to a variety of environmental stressors have been reported in
birds (Edens and Siegel 1975; El Halawani et al 1973; Hangalapura et al 2004b). The effects
of exogenous glucocorticoids are not constant and depend on the molecular species of
glucocorticoid employed, the route and the time of administration (Joseph and Ramachandran
1993; Sapolsky et al 2000). Glucocorticoids alter several metabolic and immunological
processes. The pre-eminent effect of glucocorticoids upon metabolism is their ability to
increase circulating glucose concentrations. This is accomplished through a number of
mechanisms including stimulation of appetite and gastrointestinal transit time (Santana et al
1995; Tur et al 1989). Despite the increase in food intake, there is a remarkable decrease in
growth and body weight gain in chickens (Hayashi et al 1994; El-Lethey et al 2001),
principally due to an increase in net muscle protein catabolism (Hayashi et al 1994; Sapolsky
et al 2000). Corticosterone also stimulates gluconeogenesis (particularly in the liver),
mobilization of amino acids from extrahepatic tissues, inhibition of glucose uptake in muscle
and adipose tissue, and stimulation of fat breakdown in adipose tissue (Siegel and Van
Kampen 1984).
Glucocorticoids can cause suppression of immune functions e.g. suppression of MHC-II
expression, IL-1, IL-2, IL-3, IL-4, IL-5, IL-6, IL-12 (Griffin 1989; Sapolsky et al 2000),
TNFα and interferon gamma production (Isobe and Lillehoj, 1992, 1993). Daynes and Araneo
(1989) reported that exogenous glucocorticoids suppress Th2 responses but enhance Th1
responses in mice. However, other investigators have reported enhancement of the immune
functions: stimulation of immunoglobulin synthesis by cultured B cells (Cupps et al 1985), T
cell responses (Wiegers et al 1993; 1994) and TNFα and IL-6 production (Barber et al 1993).
Claman (1988) showed that not all animal species are impacted equally by corticosteroids,
some are more sensitive (e.g., chicken, mouse, rat, rabbit and hamster) than others (e.g.,
primates, guinea pig, sheep, cattle, pig).
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2.3 Body temperature and avian thermoregulation
The chicken, like mammals, is a homeotherm, in that it maintains a relatively constant body
temperature over a wide range of environmental conditions (Freeman 1971). In adult
chickens, the body temperature varies between 41°C and 42°C (Brake and Thaxton 1979).
Under normal conditions the temperature of the bird is above that of the environment and, as
a consequence heat is constantly being lost to the environment by a combination of radiation,
conduction, convection and evaporation (Freeman 1971). As the ambient temperature rises
the respiratory rate increases and at around 29.4°C (ambient temperature) when the body
temperature reaches 42-42.5°C the birds begin to pant (or exhibit thermal polypnea) (Frankel
et al 1962; North and Bell 1990). When this response (panting) is prolonged the bird may
experience respiratory alkalosis, due to excess loss of CO2 from the body (Borges et al 2004).
In addition to panting, the birds assume unusual physical positions or change behaviour in
order to help heat loss e.g. by standing with the neck extended and wings held away from the
body and by effecting vasodilation in the naked parts of the body so that the heat can be
dissipated from these areas (Freeman 1971). The upper lethal body temperature is 45-47°C
(Randall 1943). Conversely, when the ambient temperature is low, and the heat loss exceeds
heat production, the birds increase their catabolic rate in order to prevent a fall in core
temperature. The feathers are fluffed out to increase insulatory protection and the birds will
crowd together to reduce the effective surface area presented to the environment (Freeman
1971; Dawson and Whittow 2000). They will also sit so that the heat loss from the
unfeathered portions of the legs is reduced with the head tucked under the wing (Freeman
1971). The lower lethal body temperature is approximately 23°C.
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2.3.1 Physiological changes due to effect of heat or cold
Chickens subjected to high environmental temperatures exhibit many physiological and
behavioural changes which allow them to re-establish a heat balance with their surroundings.
One of the primary effects of high environmental temperature on a flock is a reduced feed
(and energy) intake, leading to depressed growth rates (Wilson 1948; Vo et al 1978; Suk and
Washburn 1995). Above the upper thermoneutral level, energy demands rise to power the
active cooling mechanisms used by the bird but because appetite is reduced by the elevated
temperatures health problems ensue. Darre and Harrison (1987) reported that heat distress
caused blood glucose concentration to increase. Borges et al (2004) reported that heat stress
alters the proportion of heterophils (increased) to lymphocytes (decreased) in blood and
decreased hematocrit values occur (Deaton et al 1969; Kubena et al 1972; Vo et al 1978).
Haemoconcentration is associated with lower environmental temperatures (7°C versus 22 or
32°C) (Huston 1960; Deaton et al 1969). Blood pressure is elevated during winter months and
lowered during summer months (Rosenthal 2004; Ulmer et al 2004).
Cold weather has been reported as an important factor that triggers the onset of ascites in
chickens. The most frequent cause of ascites in broilers is increased portal pressure,
secondary to right ventricular failure (RVF), resulting in liver damage although decreased
osmotic pressure and increased vascular permeability also occur (Julian 2005). Hypothermia
causes increased oxygen demand with an associated increase in cardiac output. Because the
lung volume and cardiovascular volume within the lung tissue is fixed, there comes a point at
which the lung can no longer accommodate any more blood being supplied by the heart and
pulmonary hypertension may result. This is the starting point for heart failure (Julian 2005).
With prolonged hypoxia, the body increases the oxygen carrying capacity in the blood by
increasing the number of erythrocytes (polycythaemia), leading to increases in the blood
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viscosity that aggravates the pulmonary hypertension (Burton and Smith 1967). Chronic
hypertension results in right ventricular hypertrophy (RVH) and causes a malfunction of the
right atriventricular valve, allowing blood to flow backwards into the vena cava. This leads to
liver congestion and seepage of liquid from the liver surface. When the rate of leakage is
greater than the capacity of the abdominal membranes to absorb the liquid, ascites develops
(Julian et al 1987).
The more liquid portion of the fluid in the hepato-peritoneal spaces can return to the vena
cava via the lymphatics and thoracic duct until venous pressure caused by RVH becomes too
high (Julian 2005). Affected broilers become dull, depressed, inactive, cyanotic and may be in
respiratory distress (Julian 2005).
2.3.2 Effect of temperature on the immune system in birds
In homeotherms not housed in a controlled environment during the winter and summer
seasons, thermo-regulation is an important energy-demanding process and therefore may
compete with immune function for nutrients (Hangalapura et al 2003). In wild birds, energy-
demanding processes such as breeding, brood care and migration, are usually accompanied by
decreased immune response and decreased health status, especially during cold seasons
(Lochmiller and Deerenberg 2000). In chickens, results of the few studies on the effect of
cold or hot stress on antibody-mediated and cell-mediated immune responses are not
consistent (Hangalapura et al 2003). Heller et al (1979) reported that when birds were
exposed to heat stress the immune response (antibody production) was enhanced. On the other
hand, there are studies by Subba Rao and Glick (1970), and Mashaly et al (2004) which
showed the immunosuppressive effect of heat stress in chickens.
Cold exposure has been reported to enhance (Subba Rao and Glick 1977) or decrease the
immune response (Regnier and Kelly 1981). These differences in results can be attributed, in
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part, to the way in which specific immunologic parameters were measured (humoral or
cellular cell immunity), or the different assay techniques and chicken breeds (Subba Rao and
Glick 1977; Heller et al 1979; Regnier and Kelly 1981; Donker et al 1990). Additionally, El-
Lethey et al (2003) showed that depending on the antigen tested, there are stress-resistant and
stress-susceptible antigen responses. They reported that chronic stress strongly suppressed
humoral and cellular immune responses assessed by lower antibody titres to sheep red blood
cells and tetanus toxoid but, in contrast, the antibody response to human serum albumin was
neither influenced by corticosterone feeding nor by depriving the birds of foraging material
(litter).
2.4 Infectious bronchitis
Infectious bronchitis (IB) is a highly contagious viral respiratory disease of chickens
characterized by tracheal rales, coughing and sneezing (Schalk and Hawn 1931) and in some
cases, renal pathology (Cumming 1962). In laying flocks there is typically a drop in egg
production and egg quality (Sevoian and Levine 1957). In meat type chickens, IB decreases
live weight gain and feed efficiency as a component of mixed infections (Cavanagh and Naqi
1997). Losses from production inefficiencies are usually of greater concern than losses from
mortality, particularly in New Zealand where concurrent infections from immunosuppressive
agents such as infection bursal disease virus (Chai et al 2001) and chicken anaemia virus
(Stanislawek and Howell 1994; Markowski-Grimsrud and Schat 2003) are uncommon.
Some researchers have postulated that the infectious bronchitis virus (IBV) is a pathogen that
has been present in the birds since the first jungle fowl (four to eight thousand years ago), and
viral changes are linked to the domestication process (Cavanagh 2002). The first description
of IB was published by Schalk and Hawn in 1931. At that time, IB was recognized primarily
as a disease affecting young chicks, but years later reductions in egg production and quality
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attributed to IBV, were reported by Van Roekel et al (1951) and Broadfoot and Smith (1954).
In 1936, Beach and Schalm established the viral aetiology, and later on, Beaudette and
Hudson (1937) made the first cultivation of the virus in embryonated chickens’ eggs. At that
time, it was assumed that all IBV strains were similar antigenically, but in 1956 Jungherr and
colleagues established that the Connecticut and Massachusetts isolates produced similar
clinical signs and lesions but did not cross-protect or cross-neutralize. In 1962, Cumming
reported that IBV was the cause of the nephrosis-nephritis syndrome seen in Australia. The
disease has been reported in broilers, layers and breeder chickens throughout the world:
Europe (Asplin 1948), South America (Garcia and Norambuena 1969), Asia (Sato et al 1955),
Africa (El Houadfi et al 1986) and Oceania (Cumming 1963). Outbreaks of IB frequently
occur, even in vaccinated flocks (Cavanagh and Naqi 2003).
2.4.1 IB in New Zealand
IBV was first isolated in New Zealand by Pohl in 1967. These initial isolates were shown to
be serologically different from strains from USA, Australia, and Germany (Bülow 1969). IBV
was isolated again in New Zealand in 1972, by McCausland et al, at which time IB was
considered an infrequent, mild illness. Soon after, a study showed that about 75% of the
broiler and layer flocks had antibodies to IB, even though vaccination was not practised in
New Zealand at that time (Lohr 1974). From 1972 to 1976 four different serotypes of IBV
were isolated, and named A, B, C, and D and Lohr (1977) showed serological associations
with strains from Australia, USA and Europe (Lohr 1976; Lohr and Locher 1983). A high
prevalence of IBV (19%) has been demonstrated recently in layers and broilers using a
reverse transcriptase polymerase chain reaction (RT-PCR) (Ramneek et al 2005). At the end
of the 1970’s a commercial vaccine was derived from the New Zealand A field strain by serial
passage in embryonated eggs (Lohr 1977). This vaccine is still the only live vaccine available
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in New Zealand and Ramneek (2000) found that it gave only partial protection to recent field
isolates. Ramneek et al (2005) and McFarlane et al (2002) found that there were no major
genetic differences between the historical strains A, B, C and D and new (1996-2000) field
isolates; 23 out of 28 isolates had >92% homology with the historical strains B,C and D and
the remainder were similar to A. When the phylogenetic relationship between the New
Zealand and other international (European, North American, Chilean, and Asian) strains was
analysed, the former were generally most closely related to the Australian strain (Group 1).
Indeed, the New Zealand A strain shared 99% of nucleotide and 98% amino acid homology
with the Australian Vic S (vaccine) and V5/90 strains (Ramneek 2000; Ramneek et al 2005).
2.4.2 Aetiology
IB is caused by avian infectious bronchitis virus (IBV), a member of the Family
Coronaviridae, Genus Coronavirus. The morphology is described as pleomorphic, enveloped,
80-120 nm in diameter, surrounded by a corona of club-shape projections or spikes about 20
nm in length (Berry et al 1964). IBV virions enclose three main structural proteins: the spike
(S), membrane (M) and internal nucleoprotein (N) (Lai and Cavanagh 1997). Also, a small
membrane protein (E) is believed to be connected with the virion envelope (Cavanagh and
Naqi 2003). The S protein comprises two or three copies of each of two glycopolypeptides,
S1 and S2. S1 is responsible for hemagglutination-inhibition (HI) and most of the virus-
neutralizing antibodies (Cavanagh et al 1988).
2.4.3 Strain classification
Classification of strains is complicated by the lack of a standard worldwide test, the use of
different names for the same type of virus, the number of diverse test systems available and,
perhaps most importantly, the nature of this virus (De Wit 2000). Classification systems can
be separated into two main groups: functional tests, which look upon the biological function
16
of a virus (immuno- or protectotypes, serotypes and epitope-types) and non-functional tests
(genotypes) (De Wit 2000). The grouping of IBV into immunotypes (Cunningham 1975) or
protectotypes (Lohr 1988) provides direct information about the efficacy of vaccine and
strains that induce protection against each other belong to the same immuno- or protectotype
(De Wit 2000). The estimation of protectotypes requires a cross-immunization study (CIS)
where vaccinated birds are challenged with different strains, which is laborious, expensive
and requires many animals and isolation facilities (Cook et al 1999a; Gelb et al 1981; Gelb et
al 1991). Dhinakar Raj and Jones (1996b) used a more economical in vitro alternative for the
CIS; the cross-inmunization test (CIT) where the challenge is performed on tracheal organ
cultures dissected from vaccinated chickens.
In the past, classification by antigenic types has been the most widely used classification, and
is based on the reaction between an IBV strain and IBV serotype-specific antibodies raised in
chickens. Dozens of serotypes of IBV have been detected; without doubt, there are many
more (Cavanagh and Naqi 2003). The technique most frequently used is virus neutralization
(VN) but HI (Lashgari and Newman 1984; Cook et al 1987) and reactivity with panels of
monoclonal antibodies is also practiced (Ignjatovic and McWaters 1991). Recently the
grouping of strains based on genetic characterization has become more common (De Wit
2000). Methods commonly used include sequencing (Andreasen et al 1991; Zwaagstra et al
1992; Ramneek 2000; Lopez et al 2006), genotype-specific RT-PCR (Keeler et al 1998),
restriction enzyme fragment length polymorphism (Lin et al 1991; Adzhar et al 1996;
Jackwood et al 1997; Escorcia et al 2000), and hybridization (Jackwood et al 1992; Kwon et
al 1993). Several studies have reported a high similarity between the genotype and serotype of
certain strains (Keeler et al 1998; Lin et al 1991; Ramnnek 2000), whereas other studies do
not (Capua et al 1998; Kusters et al 1987).
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The majority of the IBV serotypes differ from each other by 20 to 25% of the S1 amino acids
(Adzhar et al 1997; Kingham et al 2000), although several differ by up to 50% (Cavanagh et
al 1997, Gelb et al 1997). In New Zealand, the deduced amino acid sequences of the S1
protein differed by 1 – 23% between isolates (Ramneek et al 2005). The differences between
other IBV proteins do not usually exceed 15% (Cavanagh et al 2001).
2.4.4 Transmission and carriers
IBV affects chickens of all ages, and they are considered to be the only host. Genetically, IBV
is very similar to the coronavirus which causes enteric disease in turkeys (Cavanagh et al
2001), and respiratory and kidney diseases in pheasants (Gough et al 1996). Evidence is
increasing that IBV has a wider host range than was previously thought e.g peafowl and teal
(Liu et al 2005). The respiratory route of infection is by droplets expelled by coughing and or
sneezing by infected chickens. It has been reported that a strain that has been not associated
with nephrosis, can cause kidney lesions when inoculated intra-cloacally (Uenaka et al 1998).
Susceptible birds reared together with infected chickens generally develop signs of illness
within 48 hours. The transmission from farm to farm is, principally, by the movement of
birds, contaminated equipment, people and vehicles. After a bird is infected, it carries and
sheds the virus for a week or longer (Ramneek 2000). The virus has been isolated from eggs
and semen (Cook 1971) but vertical transmission has not been demonstrated.
2.4.5 Clinical signs
All ages are susceptible, but the clinical signs are more severe in young chicks (Animas et al
1994). The initial replication of IBV in the respiratory tissue causes typical, but not
pathognomonic, signs such as breathlessness, coughing, sneezing, tracheal rales and nasal
discharge (Dhinakar Raj and Jones 1997a). Inflamed eyes and swollen sinuses have also been
reported (Parsons et al 1992; Capua et al 1994). In chicks, feed intake and live weight gain
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can be reduced (Cavanagh and Naqi 2003). Hofstad (1984) reported that in animals older than
six weeks, nasal discharge does not occur as frequently, and the disease may go unobserved
unless the birds are examined carefully either by handling the birds or listening to them at
night when the birds are normally quiet. In layers, a decline in egg production and quality is
seen with or with out respiratory signs (Sevoian and Levine 1957). Broiler chickens infected
with a nephropathic strain after recovering from the typical respiratory phase may then show
signs of depression, ruffled feathers, wet droppings and increased water intake (Winterfield
and Hitchner 1962; Cumming 1969).
Generally, mortality is low if the disease is not complicated by other factors such as the
infectious agents e.g., M. gallisepticum, E. coli, immunosuppression or environmental
stressors such as ammonia or changes in environmental temperature (Ratanasethakul and
Cumming 1983; Peighambari et al 2000). As age increases chicks become more resistant to
mortality (Crinion and Hofstad 1972; Albassam et al 1986). Infection with IBV may
predispose chickens to secondary infections such as Esherichia coli (reviewed by Dhinakar
and Jones 1997a) or Ornithobacterium rhinotracheale (not present in New Zealand), which
may bring about increased condemnation at the processing plant, especially when infection
occurs in the last weeks prior to slaughter
In New Zealand, uncomplicated infections with IBV are mild under ideal environmental
conditions (Ramneek 2000) and disease outbreaks occur when there are changes in certain
housing and management practices, even in vaccinated flocks (Findon 1987).
2.4.6 Pathogenesis
IBV initially infects the upper respiratory tract, where it is restricted to the ciliated and
mucus-secreting cells (Dhinaker Raj and Jones 1997a). The virus titres are maximal in the
nose and trachea within three days of infection and remain so for two to five days (Hostad and
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Yoder 1966). Small areas of pneumonia may be observed in the lungs, although IBV is not
considered to cause pneumonia (Dhinaker Raj and Jones 1997a). Deciliation of the ciliated
epithelia of the nasal passages and trachea follows infection. Infection is commonly followed
by secondary bacterial infections (e.g., Escherichia. coli), which can be the main cause of
debilitating disease (Vandekerchove et al 2004). Subsequent to the initial viral replication in
the epithelial cells of the respiratory tract, a viremia occurs and the virus is widely circulated
to other tissues such as kidney, oviducts, testes, oesophagus, proventriculus, duodenum,
jejunum, bursa of Fabricius, caecal tonsils, rectum and cloaca (Jones and Jordan 1971;
McMartin 1993; Dhinaker Raj and Jones 1997a). IBV can establish persistent infections in
chickens (e.g., kidney and caecal tonsils). Virus may not be detectable after the initial period
of replication, but may be excreted at the beginning of egg production (Jones and Ambali
1987).
2.4.7 Lesions
Infected chickens have accumulations of serous, catarrhal or caseous exudate in the tracheal,
nasal passages and sinuses. If complicating factors are present air sacs may appear cloudy or
contain a yellow caseous exudate (Cavanagh and Naqi 2003). In laying hens the virus causes
glandular hypoplasia in the oviduct that leads to reduction in the synthesis of albumin
proteins, especially ovomucin, lysozyme and other major proteins which constitute the
structural matrix of the thick albumen, and lead to ‘watery-whites’(Butler et al 1972). Effects
of IBV on the male reproductive tract have not been reported (Dhinakar Raj and Jones
1997a).
After infection with nephropathogenic strains, the kidneys become pale and swollen and urate
deposits may form in the kidneys and ureters (Cumming 1963). The virus causes granular
degeneration, vacuolation and desquamation of the tubular epithelium with massive
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infiltration of heterophils in the interstitium in acute stages of the disease (Chen et al 1996)
which may lead to wet droppings. Gough et al (1992) reported that the strain 793/B was
isolated from broiler breeding flocks with bilateral myopathy in both deep and superficial
pectoral muscles. Even though IBV has a wide tropism for gut tissues, no gross or histological
changes have been reported (Dhinakar Raj and Jones 1997a).
2.4.8 Diagnosis
IBV infections can be diagnosed by detection of the virus itself or part of it, or a specific
antibody response (De Wit 2000). Traditionally, virus isolation (VI) is the first step in the
detection of IBV. The trachea is a primary target for IBV, and so is usually chosen as a
sampling site, especially within the first week of infection (McMartin 1993; Dhinakar Raj and
Jones 1997a; Cavanagh and Naqi 2003). Ambali and Jones (1990) found that the highest virus
titres are reached in the trachea between five to ten days p.i. One week after clinical signs
have appeared, the possibilities of isolating IBV are higher in cloacal swabs or caecal tonsils,
kidney or oviduct than in the trachea (Cook 1968; Alexander and Gough 1977; El-Houadfi et
al 1986; Ramneek 2000; Cavanagh and Naqi 2003). IBV can be isolated in different
biological systems such as embryonated eggs (Jordan and Nassar 1973) and chicken tracheal
organ cultures (Darbyshire 1978). VI is a sensitive technique but can be laborious, time
consuming (should be passaged through embryonated eggs or tracheal organs several times
for adaptation) and costly (De Wit 2000). Also, VI observations are not, in themselves,
sufficient to confirm the presence of IBV. The presence of the virus must then be confirmed
by ELISA, immunohistochemistry, nucleic acid analysis, or electron microscopy. There may
be circumstances when VI fails, for example when IBV is inactivated (high temperature) or a
double infection with IBV and another virus occurs. In such instances these techniques, or
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others such as agar-gel precipitation test (AGPT), IFA, immunoperoxidase assay (IPA), may
be used directly. In general, these methods suffer from low sensitivity.
Detection of the IBV genome is sensitive and rapid (Jackwood et al 1992; Ramneek et al
2005) especially when used directly with infected tissue and has superceded many of the other
assays. As, these techniques do not distinguish between infectious and non-infectious virus
particles they are particularly useful for testing degraded diagnostic samples. Currently, the
most common techniques utilize the RT-PCR and amplify a genomic region conserved across
viral strains. After amplification, the PCR product may be characterized by sequencing and
comparison with a database (Ramneek 2000; Lopez et al 2003) or restriction fragment length
polymorphism analysis (Kwon et al 1993).
IBV infections can also be diagnosed by detecting the appearance or rise in titre of IBV-
specific antibodies which occurs one week after infection (Ramneek 2000; Pei and Collisson
2005). Generally, for accuracy, paired samples are required. The first sample is taken at the
onset of disease, and the second sample two to four weeks later (De Wit 2000). Alternatively,
a specific IgM ELISA has been used to detect recent IBV infections (De Wit et al 1998)
because of the limited lifespan of this antibody isotype. All IBV serotypes have both group
and type-specific epitopes (the latter are present in the S1 protein (Cavanaght and Naqi 2003).
In general the serological tests (ELISA, haemaglutination inhibition, immunofluorescence and
immunodiffusion) bind to group, as well as to type-specific, antigens, so do not differentiate
serotypes (Cavanaght and Naqi 2003).
Virus neutralisation is the reference test for the detection of type-specific antibodies (Cowan
and Hitchner 1075). The specificity is very high after a single IBV inoculation (Karaca and
Naqi 1993; De Wit et et al 1997), although it is not well standardised internationally, making
it difficult to compare results between laboratories (De Wit 2000). Other disadvantage is that
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the method requires reference strains and sera. That disadvantage can be avoided using
monoclonal antibodies, but they are limited and do not cover the full range of IBV serotypes
(Koch et al 1986).
2.4.9 Treatment
There is no specific treatment for IB. Some improvements in the management practices can
help to decrease the impact of the virus: elimination of cold stress, overcrowding, and
attempts to reduce live weight losses (e.g., increase the number of feeders). With
nephropathic strains an additional supply of electrolytes can help in the balance of sodium and
potassium (Cumming 1969).
2.5 Poultry immune system
The immune system in poultry, like that of humans, has developed a number of defence
strategies to neutralise a wide range of pathogens. When pathogens enter the body they are
repelled by the first line of defence, the innate immunity, such as physical and chemical
barriers that prevent entry of the pathogen, and cellular and soluble components that are
designed to eliminate the pathogen once it has gained entry (Erf 2004), such as phagocytic
cells (Qureshi et al 2000), complement (Koppenheffer 1998), and natural killer cells (Sharma
and Okazaki 1981).
Pathogens that cannot be denied access through physical barriers or controlled by the innate
immune defence face a highly specific response (adaptive immunity), resulting not only in
elimination of the pathogen but also as protection against repeat encounters (memory) with
the same pathogen (Erf 2004). Adaptive immunity is mediated by a variety of cells. T-
lymphocytes have helper or cytotoxic functions. The former help in the production of
antibody by B cells and increase the microbicidal activity of macrophages and the latter are
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involved in the lysis of virus-infected cells (Paul 2003). B cells are directly involved in
humoral immunity and the production of antibodies against antigen (Sharma 2003). The
immune cells reside in primary or secondary lymphoid organs. The thymus and Bursa of
Fabricius increase in size until 1-2 months of age respectively and are the primary lymphoid
organs. Secondary organs include the spleen, Harderian glands, bone marrow, conjunctival-
associated lymphoid tissue, bronchial-associated lymphoid tissue and gut-associated
lymphoid tissue. Chickens do not have lymph nodes but do have lymphoid nodules along the
course of the lymphatics (Sharma 2003).
2.5.1 Immune response against IBV
2.5.1.1 Innate Immunity
In chickens, heterophils constitute the first line of defence against infectious agents and are
the first cells to be recruited to the site of infection. However, it has been reported that
heterophils have no effect on IBV multiplication (Fulton et al 1993). The role of the
macrophage in IBV infections has not been totally determined yet, while no alterations in
natural kill (NK) cell activity have been found post inoculation with IBV (Wakenell et al
1995). Pei et al (2001) reported that rChIFN-α inhibited replication of IBV (Beaudette strain)
in chicken kidney cells (CKC), in a dose-dependent manner. Also, the supernatant from
cultured spleen cells inhibited tracheal ring ciliostasis caused by IBV. Otsuki et al (1991)
found no differences in IFN-γ levels of unstimulated lymphocytes from IBV-resistant and
IBV-sensitive lines of chickens.
2.5.1.2 Humoral immunity
Chickens develop a humoral response to IBV infection, measurable by ELISA, HI or VN tests
(Gough and Alexander 1977; De Wit et al 1992; Wilcox et al 1983). However, the precise
24
role of antibody in the control of IBV infections remains controversial. Several studies have
shown that circulating antibody titres do not highly correlate with protection from IBV
infection. Raggi and Lee (1965) reported a lack of correlation between infectivity, serological
response and challenge with IBV vaccine. Gough and Alexander (1979) reported no
correlation between HI antibody titres and susceptibility to challenge, as measured by re-
isolation of virus from the trachea. Nevertheless, other studies demonstrated that humoral
immunity plays an important role in disease recovery and virus clearance. Chandra (1988)
showed that chickens treated with cyclophosphamide (B-cell ablation) had more clinical signs
and more severe histopathological lesions in the kidney than untreated birds infected with
IBV. Cook et al (1991), found that after inoculation with IBV, bursectomised chicks
experienced a more severe and longer lasting infection than intact chicks, but mortality was
unchanged. It has also been reported that high titres of humoral antibodies correlate well with
the absence of virus re-isolation from kidneys and genital tract (Gough and Alexander 1977;
MacDonald et al 1981; Yachida et al 1985) and protection against drop in egg production
(Box et al 1988).
Following infection with a live IBV vaccinal strain there is a primary IgM response. As
expected, the primary IgM response peaks, and declines, before that of the IgG response
(Martins et al 1991). The secondary IgM response i.e. in response to a second challenge,
peaks at the same time as that of IgG, but declines faster Anti-IBV IgG is detected in serum
by ELISA at seven days post infection (p.i), reaching maximum levels at two weeks p.i and
remaining positive until at least ten weeks p.i. (Pei and Collisson 2005). Dhinakar Raj and
Jones (1996a) reported IgG antibody content was highest in tears on Day 7 post-infection
(p.i.) and was still detectable on day 23 p.i. and that significant levels of IgG antibody were
present in oviduct washes on days 7 and 23 p.i.
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Holmes (1973) and Toro and Fernandez (1994) reported that local antibody (IgA) plays a role
in protection of the respiratory tract, principally in the prevention of re-infections. On the
other hand, Gelb et al (1998) found that some chickens with high tear IBV antibody titres
were susceptible to IBV and that some chickens with low tear titres were protected. Dhinakar
Raj and Jones (1996a) reported that tears showed the highest IgA antibody concentration on
day 7 p.i. but this decreased to an insignificant level by day 17 p.i..
Pei and Collisson (2005) reported that antibody secreting cells (ASC) from the spleen and
peripheral blood, reached their peak between seven and ten days p.i., correlating with the
maximum virus load in the lungs, suggesting that ASC are not protective. These ASC (plasma
cells) survived without antigen stimulation for at least 18 weeks p.i. Memory B cells in
peripheral blood and spleen are generated from 3 to 10 weeks p.i and are important for
protection against IBV infection (Pei and Collisson 2005).
2.5.1.3 Cellular immunity
Dhinakar Raj and Jones (1997b), using a T cell compromised chicken model, reported that T
cell immunity is important in limiting the severity and lethality of the infections with IBV
rather than clearing virus (measured by virus isolation). Studies reported by Seo and Collisson
(1997), Seo et al (2000) and Collisson et al (2000) have shown a cytotoxic T lymphocyte
(CTL) response that correlates with recovery from infection after an IBV infection. The CTL
response is detected as early as day 3 p.i. with (22.9% lysis), peaks at 10 day p.i. (82.8%
lysis) and falls to 46%, 38% and 23% on days 15, 20, and 30 p.i respectively (Seo and
Collisson 1997). The majority of the CTL activity is dependent on the presence of CD8
+
cells,
but a minority of effector cells may have a CD4
+
phenotype (Collisson et al 2000). Seo et al
(2000) made an adoptive transfer of effector T cells, and showed that CD4
-
/CD8
+
T cells
bearing αβ T cell receptors, collected at 10 days p.i. with IBV, controlled acute IBV infection
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in naïve chicks. Pei et al (2003) found that IBV-specific CD8
+
memory T cells generated at 3
to 6 weeks p.i. can protect sygeneic chicks from acute IBV infection.
In summary, the CTL response of chicks to IBV infection plays a critical role in impeding the
injurious effects of virus during acute infection. Later control of infection depends on
antibody, especially IgG, which is likely to play a major role in preventing recrudescence of
infection
2.5.1.4 Passive immunity
Maternal-derived antibody (MDA) can be transferred via the yolk sac to neonatal chicks. This
antibody (largely IgG) can interfere with the immunity generated by live vaccines of the same
strain (Klieve and Cumming 1988). MDA produced by vaccination of breeders can provide
protection of their chicks against IBV challenge until one week of age (Mockett et al 1987),
but may not prevent viral infection of the respiratory system. Chicks hatched with high levels
of maternal antibody had excellent protection (>95%) against IBV challenge at day 1 of age,
but not at 7 days (<30%) (Mondal and Naqi 2001). However, Yachida et al (1981) showed
that MDA did not reduce the titre of re-isolation of challenge virus given at two days of age.
2.5.2 Vaccination against IBV
2.5.2.1 Types of vaccines
Live, inactivated and DNA vaccines are available for IB immunization. Live vaccines are
usually attenuated by serial passage in chicken embryos. Protection in the respiratory tract
afforded by a single live vaccine has been reported by Gough and Alexander (1979) to be as
short as six to nine weeks. These vaccines are commonly used in broilers (rarely in New
Zealand) and as a priming vaccine in layers and breeders. Live vaccines can be administered
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by eye drop, intratracheally or intranasally, as a coarse spray aerosol and in the drinking
water.
Inactivated vaccines were developed with the objective of giving long-lasting immunity to
hens and to protect against drops in egg production. However, single applications of
inactivated virus vaccine induced little or no protection against egg loss (McDougall 1969;
Box et al 1980; Muneer et al 1987) and no protection against loss of ciliary activity in the
trachea (Martins et al 1991). These vaccines usually are given after ‘priming’ with the live
virus and are administered a few weeks before egg production commences (Cavanagh and
Naqi 2003). More recently, vaccines have been produced using DNA recombinant techniques.
Song et al (1998) reported that a rS1 glycoprotein expressed by a recombinant baculovirus
can induce a protective immune response as well as an antibody response. Kapczynski et al
(2003) developed a DNA vaccination from the S1 gene, that when given either in ovo or
intramuscularly, provided some protection against clinical disease after homologous IBV
challenge. Tarpey et al (2006) reported promising results with the use of an experimental
recombinant in ovo vaccine, based on the Beaudette strain which expressed a S1 protein from
either Beaudette (Beau-R) or virulent M41 strains (BeauR-M41).
2.5.2.2 Vaccination programs
Different strains of IBV have been used as vaccines. The Massachusetts serotypes are used
widely around the world because initial isolates from many countries were of that serotype
(Cavanagh and Naqi 2003). Cross-protection tends to diminish as the degree of amino acid
identity between the S1 proteins of two IBV strains decreases (Cavanaght el al 1997). The use
of Ma5 vaccine (Massachusetts serotype) at 1 day old and the heterologous 4/91 vaccine at 2
weeks of age, was shown to be highly effective in protecting the respiratory tract of specific-
pathogen-free chickens from many serotypes, isolated from disease outbreaks in different parts
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of the world (Cook et al 1999b). That is the use of IB vaccines containing two or more
antigenic types of IBV broadens the protection against challenge with IB isolates of many
different serotypes.
In the New Zealand poultry industry a live vaccine (strain A) and an inactivated vaccine
(Massachusetts type) are available. Findon (1987), reported that the live New Zealand strain
A virus (49
th
egg passage), protected layers from IBV infection on farms with good
management techniques but vaccination on another commercial farm gave less than ideal
protection, due to intercurrent disease. Ramneek (2000) found that live A vaccine gave only
partial protection in commercial broilers following experimental challenge with isolates C and
D, as measured by lessening of pulmonary and renal histological lesions and viral excretion..
Timing of vaccination varies due to the titre of maternal antibody in chicks, vaccination
methods used, and the needs or aims for control of IB, as well as other flock diseases. Broilers
are commonly vaccinated by spray with live mild strain vaccines such as Massachusetts,
H120 or Connecticut in the hatchery. Antibodies decline over time and, therefore, it is
sometimes necessary to re-stimulate the immune system with subsequent live vaccinations (at
10 or so days of age), especially if the field challenge is high (Cavanagh and Naqi 2003). A
typical vaccination programme (America, Europe) for parents and commercial layers involves
three to four live vaccinations followed by a killed vaccination with a 3-week break between
live vaccinations and a 6-week spread between the last live and killed vaccine. In farms with
high IBV challenge, live boosting may be considered in the laying facility every 6-8 weeks in
addition to the administration of a killed vaccine. In New Zealand, because of the mildness of
the disease some layers may receive two live vaccines in rearing or alternatively one live and
one killed vaccine. Broilers are rarely vaccinated.
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Summary
IB is an important endemic disease of the poultry industry of New Zealand. IB shows winter
seasonality but the cause of that is not clear. Some poultry meat consumers, and animal
welfare lobbyists, in New Zealand (as in many other developed countries) are asking for the
return to more ‘natural’ husbandry systems such as the rearing of free range chickens. Under
this production system the birds may face many stressors such as extreme ambient
temperatures that can put in jeopardy their homeostasis and so affect their welfare. The effect
of the temperature on the immunity against endemic pathogens is not clear and studies show
inconsistent results. Corticosterone is believed to be the principal glucocorticoid released by
the birds in order to moderate the defence reactions to stress but its role in mediating the
effects of temperature change on immune function is not clear.
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Chapter 3
THE INFLUENCE OF ENVIRONMENTAL FACTORS ON THE PREVALENCE OF
INFECTIOUS BRONCHITIS
3.1 Introduction
Seasonality of infectious diseases has been observed to exist since at least 400 BC, when
Hippocrates stated ‘whoever wishes to investigate medicine properly should proceed thus: in
the first place to consider the seasons of the year’ (Hare 1975).
Because seasonal cycles of infectious diseases are so universal and no single theory has
proved satisfactory, explanations about their cause abound. More than one explanation or
combination of explanations may be true and include: pathogen appearance, disappearance or
changes in the genome, and environmental or host changes (Dowell 2001). Many diseases
caused by the coronavirus such as severe acute respiratory syndrome (SARS) (Dowell and Ho
2004) and infectious bronchitis (IB) virus (Dhinakar Raj and Jones 1997b), exhibit winter
seasonality with the presence of persistent virus carriers . A high flock prevalence of IBV has
been demonstrated recently in New Zealand using RT-PCR, from samples collected during
the winter-spring period (Ramneek et al 2005).
The peaking of respiratory diseases during winter on poultry farms is likely to be due to
environmental factors such as ineffective ventilation because of the need to conserve heat.
Reduced ventilation usually results in an increase in air pollutants, such as ammonia, carbon
dioxide, dust and air-borne microorganisms (Anderson et al 1966). Certain factors are known
to exacerbate clinical diseases or affect the immune responses: low/high environmental
temperatures (Ratanasethakul and Cumming 1983; Henken et al 1983; Regnier and Kelly
1981), high ammonia levels (Anderson et al 1964; Kling and Quarles 1974), low levels of
oxygen (Olander et al 1967), inspirable dust (Willis et al 1987), deprivation of foraging
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material (El-Lethey et al 2003), and high levels of circulating corticosterone levels (El-Lethey
et al 2003). Very few of these factors have been studied in relation to IBV infection with the
exception of cold temperature (Ratanasethakul and Cumming 1983) and atmospheric
ammonia (Kling and Quarles 1974). The accurate estimation of risk factors associated with IB
disease events is critical to the determination of the benefit–risk ratio and the most cost-
effective use of preventive therapies (Tonkin et al 2003).
The aim of this study was to firstly, determine the prevalence of IBV in broilers within the
Canterbury province of New Zealand in late winter and spring and secondly, to determine
whether a particular management or environmental factor was related to the presence of IBV.
3.2 Materials and methods
3.2.1 Farms
The farms eligible for the case control study were suppliers for a major broiler producer in
Canterbury, New Zealand. Ten farms (the average size was 77,000 birds), with birds between
3 to 4 weeks of age, were selected from a total of 29 farms that produced approximately 60-
70% of the broiler chickens of Canterbury. The chicks arrived at the farms from a hatchery
where a live and dead vaccination programe was carried out in the breeders (chicks had
maternal antibody titres of approximately 3000 (ELISA TropBio Pty Ltd, Queensland,
Australia), which declined to negative levels by 3 weeks of age. The broiler chicks themselves
were not vaccinated against IBV.
Birds from one of the sheds of each farm had some production (reduced live-weight gain) or
respiratory signs (lacrimation, sneezing, coughing within the last 5 days) that suggested the
presence of IB. Such a shed was defined as a case shed, and a matched control shed was
selected as a shed containing birds that were believed not to have been affected by IB. That is,
each farm had a case and a control shed within which flocks had a high degree of similarity
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with respect to the age of birds, number of drinkers, nature of food and litter (wood shavings).
All sheds were a controlled environment. An attempt was made to minimize contamination
between sheds by personnel adhering to certain hygiene activities: changing of overalls,
disinfection of boots. The most common ventilation system was ‘cross ventilation’, where air
is drawn into the shed due to negative pressure by fans, circulated across the width of the shed
and out of the shed through vents on the opposite wall. Fans ran for approximately 30 sec
every 5 minutes at three days of age, which increased over the next three weeks to 50% of the
time (running for 2.5min in every 5min).
The stocking density of the birds in the farms was 21 birds per square metre. Shed separation
varied from farm to farm but there was a minimum distance of 10 metres between them.
Lighting patterns varied from farm to farm; the most common system was 4 hours on-2 hours
off. The birds ate standard grower pellets with a protein level of 21%.
3.2.2 Clinical signs and detection of IBV
In each shed, 6 birds were randomly selected from the clinically unaffected population.
In flocks unvaccinated to IBV within a region of high IBV prevalence (a previous NZ
study by Lohr (1974), showed 69 % IBV seroprevalence), the number of birds needed
to be sampled in order to give 80% test power with 95% confidence was 6 (Cannon and
Roe 1982).
Birds were checked individually for tracheal rales (a sound emanating from the bronchi, also
detected by vibrations when holding a chick), nasal and ocular discharge.
The trachea of each of the 6 live birds was swabbed by inserting a cotton swab into the
trachea and gently swabbing the wall. Additionally, cloacal swabs from the same birds were
taken by inserting a cotton swab deeply into the vent followed by rotation against the mucosal
wall. The tracheal or cloacal swabs were pooled together (each shed) and then placed in 20 ml
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of transport media (TM) at 4 °C (Poulvac Sterile diluent, Fort Dodge Animal Health, USA)
containing antibiotic (Enrofloxacin 10%, Bayer, New Zealand). The samples were centrifuged
in the laboratory at 3000g 4 °C for 10 minutes, then 200 µl of the fluid plus 500 µl TRizol
(Life Technologies, USA) and 100 µl of Chloroform (Biochemical, England) were vortexed
for 10 seconds. This was followed by an incubation period of 10 minutes at room temperature
and centrifugation at 13000 rpm for 15 minutes at 4 °C. The upper colourless phase was
collected in separate tubes and mixed with 250 µl isopropanol (Analar R, Biochemical,
England) , followed by incubation at room temperature for 10 minutes. Again the samples
were centrifuged at 13000 rpm for 15 minutes at 4 °C. The pellet was added to 400 µl of 70 %
Ethanol (Biochemical, England), vortexed for 3 seconds and centrifuged (13000 rpm). The
supernatant was discarded and the pellet was air dried in a sterile environment. Finally the
pellet was dissolve in 20 µl of diethylpolycarbonate-treated water and stored at – 20 °C.
RT-PCR reactions were carried out using the ‘Titan One Tube RT-PCR System’ (Roche
Diagnostics GmbH, German) described by Ramneek (2000) and Lopez et al (2006). In the
RT-PCR reaction, the primers NT1 and NT2 (Ramneek 2000) were used to bind to the N-
terminus of the S1 gene (+116-308) and bracketed a hypervariable region (HVR1) (Cavanagh
et al 1988). The RT reaction was carried out at 45 °C for 30 minutes in a Gen Amp PCR
system 2400 PCR machine (Applied Biosystems, USA), followed by a pre-PCR denaturation
at 94 °C for 20 seconds, denaturation at 94 °C for 20 seconds, annealing at 50 °C for 15 sec,
polymerisation at 72 °C for 40 seconds for the first 10 cycles, and a incremental 5 seconds for
each of the next 25 polymerisation cycles. An additional polymerisation step followed at 72
°C for 7 minutes. The PCR product was visualised on a 1 % agarose gel in Tris borate EDTA
buffer containing ethidium bromide (0.5 µg/ml), using an ultraviolet transilluminator (UVP
Lifesciences, UK).
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3.2.3 Ambient measurements
The levels of ammonia, oxygen, carbon dioxide, and relative humidity, were measured daily
(9 am in the morning after a feeding period). Duplicate measurements were taken, 0.5 m
above the litter surface in the the middle of the shed using a Multiwarn II gas detector (Dräger
AG, Lübeck, German). Litter humidity was measured by manual compression in a scale of 1
to 4 (A score of 1 being dry litter with moisture around 20% and 3 is the highest level
considered acceptable for broiler production – an in house company score). The mean outdoor
temperature for the period of time when the measurements were made (August) was 10.3 °C
and the monthly rainfall was 86 mm (NIWA Science, National Climate Centre, NZ).
3.2.4 Questionnaire and data analysis
A questionnaire was completed by the farm manager in order to provide information about
certain farm characteristics such as: flock size, management practices and environmental
factors (see appendix I). A descriptive analysis was completed to provide summary statistics
for all variables in the data set. Binary logistic regression analyses were conducted to assess
associations between the presence of IBV and various risk factors, using MINITAB Statistical
Software (Minitab Inc, Pennsylvania, USA).
3.3 Results
IBV was detected by RT-PCR in 50% of the farms visited (Figure 3.1), from 5 of the 10 case
sheds and 1 of the 10 control sheds. The virus was found in either the trachea or the cloaca (1
farm trachea, 2 farms cloaca), or in both (2 farms) (appendix II). In only 2 of the 5 positive
farms where IBV was detected was there accompanying clinical respiratory signs suggestive
of IB (lacrimation, sneezing, coughing). Ambient humidity was the only risk factor studied
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that showed a significant inverse relationship with the prevalence of IBV (odds ratio with
95% confidence levels less than, and excluding, 1 are significant and depict a negative or
inverse association) (Table 3.1).
Figure 3.1. RT-PCR amplimers using the primers NT1 and NT2. Lane 1. MW marker, Lane
2. Blank reation, Line 3. Negative control, Lines 4-7. Samples containing IBV
Table 3.1. Logistic regression analysis of factors associated with the presence of IBV in
broiler farms.
OR= Odds Ratio, CI= Confidence interval, SEM= Standard error of the mean
*Measurement taken 0.5 m above litter surface
Risk Factor P Value OR 95% CI Mean (Range) SEM
Temperature* 0.99 1 0.74-1.35
22.5C
(20-29°C)
0.720
Relative humidity* 0.05 0.92 0.84-1
75.3%
(50-97%)
3.490
Ammonia* 0.4 1.03 0.96-1.1
16.7 ppm
(0-50 ppm)
3.100
Oxygen* 0.25 0.07 0.0-7.4
20.4 %
(20.0-20.9 %)
0.054
Carbon dioxide* 0.8 0.69 0.01-60.39
0.31%
(0.0-0.8%)
0.040
Litter humidity 0.1 4.6 0.74-28.47 2.6 (1.0-3.5) 0.220
300 pb
200 pb
100 pb
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3.4 Discussion
There is a belief that IBV infection in broilers in New Zealand is under-diagnosed, particularly
as its prevalence has been largely based on seroconversion and this may be misleading as birds
are frequently tested at slaughter (35-40 days old) and have had little time to seroconvert, thus
leading to false negatives. A study conducted by Lohr (1974) showed that 69% of the New
Zealand broilers and 75% of layers were sero-positive to IBV, as detected by neutralising and
precipitating antibodies. Ramneek et al (2005) showed the farm prevalence (predominantly
broilers) of IBV to be 19%, using RT-PCR. Ignjatovic and Sapats (2000) reported that IBV is
prevalent in all countries with an intensive poultry industry, with the incidence of infection
approaching 100% in many locations. Shapouri et al (2004) reported a prevalence of 42.8% in
Iran (strain 4/91), Gutierrez-Ruiz et al (2000) reported a prevalence in Mexico of 56.5% and in
Italy Capua et al (1994) showed a prevalence of IBV of 81.8% (strain 624/I). In the present
study, IBV was detected by RT-PCR in birds from 5 of the 10 case sheds and 1 of the 10
control sheds. In 2 of the 5 case sheds where IBV was detected there were accompanying
clinical signs suggestive of IB. Infectious bronchitis may resemble other respiratory diseases
such as Newcastle disease, laryngotracheitis and infectious coryza. Newcastle disease has not
been reported as a clinical entity in New Zealand (Durham et al 1980), but an avirulent
lentogenic strain is occasionally detected in commercial poultry flocks (Howell 1992).
Larnygotracheitis shows more marked respiratory signs than IB (Cavanagh and Naqi 2003)
and is uncommon in broilers in New Zealand (Lohr and Saywell 1976; Poland 2006).
Infectious coryza can be differentiated on the basis of facial swelling that rarely occurs in IB
and was not present in these broilers.The lack of clinical disease in the field where IBV is
present could be attributed to a number of factors, including: mildness of the strains found
(IBV), good management practices and the absence of major immunosuppressive agents such
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as infection bursal disease virus – eliminated from New Zealand since 2000 (Chai et al 2001),
chicken anaemia virus – controlled by vaccination of breeders (Stanislawek and Howell 1994;
Markowski-Grimsrud and Schat 2003) and inter-current infections such as; Mycoplasma
gallisepticum (MG) – breeders tested negative and E. coli . In addition, Ramneek (2000),
studied the pathogenicity of 5 different genotypes of IBV and found that all the strains
analysed induced only mild histological lesions and clinical signs when poultry were housed
under good management conditions, with respect to temperature, relative humidity and levels
of ammonia.
Managers of all of the flocks followed a common operation manual established by the broiler
producer, in order to follow best husbandry practice. The narrow range of values within the
environmental variables (temperatures etc) studied meant that is was difficult to distinguish
between particular management practices among farms and IBV prevalence (appendix I).
Environmental changes are the factors most often provided to explain the seasonality of
infectious diseases (Dowell 2001) and most avian respiratory pathogens exhibit an annual
increase in incidence each winter. In this study, only 2 of 10 farms exceeded the optimal
temperature for birds of 19°C to 24°C as defined by Yoder et al (1977) and one of these farms
had birds positive for IBV. A reduction in ambient temperature (constant 16°C) has been
reported to increase mortality with IBV infections (Cumming 1969) even though there were no
indications (postural adjustments, behavioural changes, or changes in food and water
consumption) that the birds were uncomfortable with the low ambient temperature. None of
the farms in this study had temperatures below 20°C.
In this trial we found a significant inverse relationship (p = 0.05; Odds Ratio (95% OR) =
0.84-1.0) between the prevalence of IBV and relative humidity (Table 1). Yoder et al (1977)
also reported that at medium temperatures (19-24°C) and low humidity, flocks infected with
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Mycoplasma synoviae and IBV had a higher incidence of airsaculitis than at a high humidity.
It has been proposed that drying of mucosal surfaces increases the probability of
transmembrane spread of bacteria (Dowell 2001). In humans, outbreaks of respiratory
syncytial virus (RSV) have been reported to peak in seasons of lower relative humidity (Chew
et al 1998). In addition, Ijaz et al (1985) studied the survival of airborne human coronavirus
and reported that a high relative humidity (80 +/- 5%) at 20 +/- 1°C, was found to be least
favourable for the survival of virus aerosols (half-life about 3 h) compared with low humidity
(50 +/- 5%) where the half-life of the virus was 67 +/- 8 h.
In this trial, there was no significant relationship between litter humidity and IBV occurrence.
Indeed in the majority of the of the sheds positive for IBV, levels of litter humidity were
higher than a recommended level of approximately 25% (North and Bell 1990). The level of
moisture in poultry litter has been positively associated with other diseases such as
coccidiosis (Waldenstedt et al 2001), poult enteritis and mortality syndrome (Edens et al
1998) and salmonellosis (Carr et al 1995).
Based on the results of previous studies (Anderson et al 1964; Kling and Quarles, 1974) it
was anticipated that higher levels of ammonia could increase the presence of IBV or
exacerbate the clinical signs found in infected birds. Kling and Quarles (1974) found that the
birds housed under high levels of ammonia had significantly smaller Bursae of Fabricius than
the controls. Anderson et al (1964) reported that 72 hours of exposure to ammonia
concentrations in the range of 20 to 50 ppm significantly increased the infection rate of
chickens with Newcastle disease virus when given as an aerosol. However, no association
was found between IBV prevalence and ammonia concentration, in the present study.
Atmospheric levels of oxygen and carbon dioxide in the poultry industry are used principally
as criteria for an efficient ventilation system. Although 55% of the sheds in this study had low
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levels of oxygen (under 20.5 %) and 40% had high levels of carbon dioxide (over 0.3 %),
there was no significant association between the levels of oxygen or carbon dioxide and
susceptibility to IBV.
It can be concluded, within the narrow constraints of the management systems described, that
humidity had an influence on the presence of IBV, but there was no influence due to
temperature, ammonia, carbon dioxide or oxygen levels, or litter humidity.
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Chapter 4
EFFECT OF THERMAL CHANGE ON IMMUNE RESPONSES AND
PHYSIOLOGICAL FUNCTION IN CHICKENS
4.1 Introduction
The poultry industry continues to experiment with ‘natural’ husbandry systems such as the
rearing of free range chickens. Under such farming systems birds that have been primarily
selected on the basis of rapid growth in optimal management systems encounter a variety of
pathogens and, at the same time, experience various kinds of physical, climatic and social
stresses (Van Loon et al 2004). Chickens subjected to high or low temperatures exhibit
several physiological and behavioural changes that allow them to re-establish thermal balance
with their surroundings (Cooper and Washburn 1998). Chickens housed at high temperatures
decreased feed consumption in order to reduce metabolic heat production and maintain
homeothermy, leading to lower growth rates. At high temperatures, decreases in blood
haematocrit values have been reported (Hutson 1965; Deaton et al 1969), although this is not
always consistent (Altan et al 2000). Conversely, Deaton et al (1969) showed that birds reared
at low temperatures (7.2
o
C) had significantly higher haematocrit levels than birds reared at
23.9 or 32
o
C.
One important cause of mortality in modern broiler operations is ascites. In an international
ascites survey of 18 countries in four continents, ascites affected 4.7% of live broilers
(Maxwell and Robertson 1997). Cold environmental temperatures have been reported as an
important factor that triggers the onset of ascites or the pulmonary hypertension syndrome
(PHS) in birds (Julian 2005).
A number of studies have indicated that birds under stress due to housing conditions (El-
Lethey et al 2003) or temperature change (Altan et al 2003) display protracted tonic
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immobility (TI) and have higher than normal levels of corticosterone in the blood. Both
parameters have been used as indicators of welfare status (Duncan et al 1986; Feltenstein et al
2003). Although Zulkifli et al (1999) reported that high temperatures did not affect the TI
interval in chickens, Hangalapura et al (2004b) showed that exposure to low temperatures
resulted in lower corticosterone levels in the plasma of chickens.
In wild birds, energy-demanding processes such as breeding, brood care and migration may
interfere with the immune response and reduce health status, especially during cold seasons
(Lochmiller and Deerenberg 2000). Thermoregulation is a significant energy-demanding
process that may compromise the immune system (Hangalapura et al 2003). Nonetheless,
results from studies on the effects of low or high environmental temperatures on humoral and
cell-mediated immune responses in chickens are inconsistent. Although Donker et al (1990)
found no effect of temperature on antibody production, Heller et al (1979) reported immune
enhancement in birds exposed to short periods of high temperatures. In contrast, Subba Rao
and Glick (1970) and Mashaly et al (2004) described immunosuppression in chickens exposed
to high temperatures for a longer period. Equally contradictory, short term exposure at low
temperatures has been reported to enhance antibody production (Subba Rao and Glick 1977)
and in vitro lymphocyte proliferation (Hangalapura et al 2003) or, conversely, to have a
negative impact on humoral (Svensson et al 1998) and cell mediated immunity (Regnier and
Kelly 1981) in birds. The variability between results can be attributed, in part, to the specific
immunologic parameters measured, assay techniques and the different breeds of chickens
used.
Infectious bronchitis (IB) is a highly contagious endemic disease of chickens characterized by
respiratory and renal pathology (Cavanagh and Naqi 1997). It is caused by the infectious
bronchitis virus (IBV) which was first described in New Zealand by Pohl (1967). Under
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optimal environmental conditions IBV NZ strains induce only mild histological lesions and
clinical signs (McCausland et al 1972; Ramnnek 2000), but cold conditions have been
associated with more severe pathology in Australia (Ratanasethakul and Cumming 1983).
There is a perception in the New Zealand poultry industry that certain environmental
stressors, principally temperature change, precipitate the onset of respiratory problems
characteristic of IB.
In this experiment environmental temperatures were changed to affect the biological function
and adaptive capacity of chickens following infection with an endemic pathogen as compared
with previous studies (El-Lethay et al 2003; Mashaly et al 2004; Hangalapura et al 2004a),
where immunological responses to novel antigens were assessed (e.g., keyhole limpet
haemocyanin; tetanus toxoid, human serum albumin). The 'affective states' of the animal
(Fraser 2004) were assessed by measuring levels of corticosterone in plasma, and tonic
immobility, and compared to various estimates of immunocompetency.
4.2 Materials and methods
4.2.1 Animals and housing conditions
One hundred day-old broiler chickens (Cobb breed) were obtained from a commercial
hatchery. The birds were placed in cages and provided with ad libitum access to a commercial
broiler ration and drinking water until 42 days of age. Following hatch the birds had steadily
decreasing ambient light (23h→ 16h per day) and temperature (30
o
C→ 20
o
C) over three
weeks. At 20 days of age the birds were weighed and randomly assigned to one of three
temperature treatments (n = 30), either high (30 +/- 2
o
C), or moderate (20 +/- 2
o
C) or low (10
+/- 2
o
C), with an ambient relative humidity of 45-55% (Figure 4.1). The rooms (one isolation
room for each treatment) were heated individually and monitored by a computerised
thermosensor.
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Experimental procedures were conducted in accordance with the requirements of the Lincoln
University Animal Ethics Committee.
Figure 4.1 Experimental design to test the effect of thermal change on immune response and
physiological function in chickens
4.2.2 Immunisation
Pure IBV (NZ strain C) stocks (Ramneek et al 2005) were amplified and titred in IBV-free, 9-
day-old chicken embryos. These were used for challenge or for the production of ELISA
antigen. As there was no access to SPF eggs at the time of the experiment (from Australia or
New Zealand) and given that the transport of IgG from the yolk to the embryonic circulation
High 30+/-2C Moderate 20+/-2C Low 10+/-2C
20 days
of age
n = 30
100 µl of 10
6
ELD50/ml IBV and sheep red blood cells (50% v/v in PBS)
22 days
of age
n = 20
28, 35, 42 days
of age
NecropsyBlood
Spleen cells: INF gammaIBV and sRBC antibodies
Corticosterone levels
Clinical signs
(score daily)
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is minimal until day 15 (<100µg/ml) (Kowalczyk et al 1985) it was decided to use
commercial 9-day-old chicken embryos. Virus was inoculated into five embryos/dilution (10
-
1
to 10
-8
) and the eggs were incubated for 7 days at 37
o
C, candling daily for mortality. On the
seventh day all the remaining eggs were opened and examined for evidence of IBV lesions in
the embryos (curling, stunting, etc). The Reed and Muench (1938) calculation was used to
calculate the EID50. From the 30 birds in each temperature tested group, 20 of similar body
weight were challenged with IBV and subsequently studied. When virus antigen was needed
for the ELISA, allantoic fluid was centrifuged at 48,000 g for three hours, heat- inactivated at
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o
C for 20 minutes (Cavanagh and Naqi 1997) and the total protein concentration was
determined by the Bio Rad DC protein assay (Porex Bio Products Group, USA).
Different concentrations of the mitogen concanavalin (Con A) and purified IBV proteins were
tested for their ability to activate splenocytes from 4-weeks-old chickens previously
challenged with IBV (Figure 4.2; Figure 4.3). Con A was used a positive control in the
splenocyte activation assays.
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Figure 4.2.Mitogenic response of chicken splenocytes to Con A with varying concentrations
of cells: 1 x 10
7
cells/ml (♦), 5 x 10
6
cells/ml (□), and 2.5 x 10
6
cells/ml (▲)
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Figure 4.3. Relationship between recall antigen (µg/ml), and cell concentration: 1 x 10
7
cells/ml (♦), 5 x 10
6
cells/ml (□), and 2.5 x 10
6
cells/ml (▲)
At 22 days of age, all birds were infected intranasally with 100 µl of 10
6
EID50/ml of IBV. At
the same time, 0.5 ml of packed sheep red blood cells (50% v/v in PBS) was injected into the
right breast muscle of all birds.
4.2.3 Blood sampling
Eight one-day-old chickens were slaughtered to measure maternally-derived serum antibody
levels against IBV (ELISA). At 14, 20, 22, 28, 35 and 42 days of age, blood samples (1.5 ml)
were taken from the brachial vein of 6 birds per treatment group within three minutes of
capture using a hypodermic syringe. Following clotting samples were centrifuged at 2,300
rpm for 10 minutes, the serum was aspirated and stored at -70
o
C. At 42 days of age blood was
taken to determine the haematocrit.
4.2.4 Clinical signs
Respiratory signs were visually scored (number of birds showing that particular sign) three
times a day, following the method described by Avellaneda et al (1994), with some
modifications (scores of 0-3 instead of 1-4, to facilitate analysis between treatment groups):
Concentration of IBV proteins (µg/ml)
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0 = no clinical signs; 1 = lacrimation, slight head movement, sneezing, coughing; 2 =
lacrimation, tracheal rales, nasal exudate, depression; 3 = more marked signs plus swollen
heads. These scores were pooled within groups, and the final score was the mean of the scores
on that day (Appendix III).
4.2.5 Lesions and mortality
The number of dead birds was recorded daily. Gross lesions in both the dead and sacrificed
birds (from each treatment group n = 6; on days 20, 22, 28, 35 and 42) were evaluated.
Air-sacs were evaluated, a modification of Kleven et al 1972, using a scale of 0 to 3: 0 = no
lesion; 1 = slight cloudiness moderate exudate; 2 = thickened with accumulations of cheesy
exudate confined to a single air sac; 3 = as in 2, but lesions found in two or more air sacs.
Trachea: 0 = no lesions; 1 = serous or catarrhal exudate; 2 = hyperaemia and caseous exudate;
3 = haemorrhage and/or caseous exudate.
Liver as described by Avellaneda et al (1994) but with a scale of 0 to 3: 0 = no lesions; 1 =
slight inflammatory process; 2 = severe inflammation and or formation of pseudomembrane;
3 = presence of pseudomembrane or haemorrhage.
Heart as described by Balog et al (2003): 0 = no lesions; 1 = mild heart enlargement; 2 =
distinct, severe heart enlargement with minimal pericardial fluid; 3= severe right ventricular
hypertrophy, copious fluid with or without fibrin clots.
Kidney: 0 = no lesions; 1 = swollen; 2 = swollen and pale; 3 =swollen and pale plus ureters
distended with urates.
Composite lesion scores were calculated by multiplying the number of birds having a
particular score and adding them together for each time point and treatment group.
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4.2.6 Body weights, haematocrit and body temperature
Body temperatures were obtained with a thermometer inserted approximately 3 cm into the
cloaca for 30 seconds (Cooper and Washburn 1998; Altan et al 2003). Temperatures were
taken at the same time (am) of the day to minimize diurnal fluctuations. The birds were
weighed after euthanasia. The haematocrit was determined using heparinised capillary tubes
followed by centrifugation in a micro-haematocrit centrifuge (Haemofuge A, Heraeus
Sepatech, Germany) for 7 minutes (Altan et al 2000).
4.2.7 Tonic immobility (TI)
Tonic immobility was induced by placing birds in a U-shaped plastic cradle covered with a
cloth and restraining them for 15 seconds, as per Jones and Faure (1981). The time, after the
15 initial seconds of restraint, was recorded until the birds made the righting response. Failure
to obtain a TI reaction lasting at least 10 seconds resulted in exclusion of the bird from
analysis. For welfare reasons the test was terminated if the birds had a righting response
greater than 15 minutes and a maximum score of 900 seconds was assigned (El-Lethey et al
2003).
4.2.8 Corticosterone
The corticosterone levels were measured by radioimmunoassay (RIA) at the Institute of
Veterinary, Animal and Biomedical Sciences, Massey University, N.Z, as described by Littin
and Cockrem (2001).
4.2.9 Antibody
Following clotting and storage at 4
o
C, the blood was centrifuged at 1500 rpm for 15 mins and
serum aspirated and stored at -70
o
C. Antibody titres to IBV were determined by Tegel Foods
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Ltd, New Plymouth, using a commercially available ELISA kit (TropBio Pty Ltd,
Queensland, Australia), containing the IBV Vic S strain as capture antigen. Antibody
production against SRBC was measured using an haemagglutination test (1:2 dilution), as
described by Wegmann and Smithies (1966).
4.2.10 Interferon gamma
The cell mediated immune response was assessed by the levels of interferon gamma produced
by splenic lymphocytes cultured in vitro (Lambrecht et al 2000). During necropsy the spleen
was aseptically removed and crushed manually into RPMI 1640 medium and the resultant
spleen cells filtered through gauze. Splenocytes were separated on Ficoll-Paque
TM
Plus
(Amersham Biosciences, Sweden), washed twice in RPMI 1640 medium (Sigma-Aldrich,
USA), and resuspended in the same medium supplemented with 10% FCS. The recall antigen
was derived from a virus stock of IBV strain C, produced in 10-day-old embryonated eggs.
One hundred µl of the recall antigen (IBV) at a concentration of 9µg/ml was added to the 96
well plate containing 100 µl of the cell suspension at a concentration of 1 x 10
7
/ml, in
triplicate, and was incubated at 39
o
C for 72 hours. An equivalent number of purified
splenocytes were cultured with Con A at 12.5µg/ml, as a positive control. Supernatants were
collected after centrifugation at 3000rpm for 15 minutes and stored at -70
o
C.
Levels of IFNγ in the culture supernatants were estimated using a sandwich ELISA
(Biosource International, USA). Plates (Nunc Maxisorp, catalog # 468667) were coated (100
µL/well) with chicken anti-IFNγ monoclonal antibody (catalog # 5C12308, Biosource, USA)
at a concentration of 2 µg/mL for 18hours at 2-8
o
C. The coating antibody was aspirated from
the wells and tapped on absorbent paper to remove excess liquid. The plates were then
blocked by adding 300 µL of blocking solution to each well (Appendix VI), for 2 hours at
room temperature. After 3 washes, the supernatants from the splenocyte cultures were added
(100 µL/well) followed immediately by the addition of 50 µL of biotinylated antibody and
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incubated for 2 hours at room temperature with continual shaking (700 rpm). After 3 washes,
100 µL/well of the chromogen TMB (catalog # SB01, Biosource, USA) was added and
incubated for 30 minutes at room temperature with continual shaking (700 rpm). Then, 100
µL/well of Stop Solution (catalog # SS01, Biosource, USA) was added. The optical density of
the plates was measured in a microfluorometer (BMG, Germany) at 450 nm, within 30
minutes of adding the Stop Solution.
4.2.11 Statistical analysis
MINITAB Statistical Software (Minitab Inc, USA) was used for calculating the confidence
intervals for body weights, haematocrit, body temperature, antibody levels, interferon gamma
production, tonic immobility and plasma corticosterone levels. A two-way table was
constructed in order to analyze the independence of the clinical signs using Chi square. The
Fisher’s exact test was used to analyse the lesion results (since Chi square was not valid for
some of the tables).
4.3 Results
4.3.1 Clinical signs
The numbers of chickens showing clinical signs of IB, that is having a clinical score of 1 or
more, differed significantly (by Chi square analysis) between the low and both moderate and
high temperature groups, from day 3 after IBV challenge (p=0.001), until day 12 (p=0.030)
peaking at day 4 (p=0.000) post challenge (Figure 4.4).
The birds under high or low temperature exhibited unusual physical positions. At high
temperature in addition to panting, the birds were standing with the neck extended and wings
held away from the body. At low temperature the feathers of the birds were fluffed out and
the birds were crowded together (Figure 4.5).
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Figure 4.4.Mean clinical score (0-3) of birds housed under high (■), moderate (●), or low
temperature (■)
Figure 4.5. (a) Bird under high temperature with its neck extended, (b) birds under low
temperature crowded together
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4.3.2 Lesions and mortality
The numbers of birds with air sac lesions housed under high and low temperature (combined)
were higher than those of birds under moderate temperature, 6 days after IBV challenge
(p=0.043: Fisher’s exact test). (Figure 4.6) (Appendix IV)
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Figure 4.6.Mean air sac lesions score of birds housed at different temperatures
The numbers of chickens with liver lesions at 13 days after challenge was greater in the
extreme (high or low) temperature rooms than in the moderate temperature room (p=0.013:
Fisher’s exact test) (Figure 4.7; 4.8) (Appendix IV)
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Figure 4.7.Mean lesion (liver) score of birds housed under different temperatures
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Figure 4.8. Liver haemorrhages found in a naturally dying bird after being housed under high
temperature for 10 days
At day 13 after challenge, the number of chickens with heart lesions (hydropericardium,
ventricular hypertrophy) (Figure 4.9) was greater in the low than in the high temperature
group (p=0.015: Fisher’s exact test). The cumulative mortality, by the end of the trial (20 days
after challenge) in the birds housed under low moderate and high temperatures was 5% (1 of
20) 0% and 10% (2 of 20) respectively.
Figure 4.9. Hydropericardium in a bird dying after being housed under low temperature for
two weeks
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4.3.3 Weight gain, haematocrit and body temperature
The chickens housed under high temperature grew significantly slower (p<0.05) than the
birds under moderate temperatures. The haematocrit levels at the end of the trial (42 days of
age; 20 days after IBV challenge) were lower (p<0.05) in the birds housed at high
temperatures compared with those housed at low or moderate temperatures (Table 4.1).
Table 4.1. Confidence intervals for mean body weight, haematocrit and body temperature of
birds housed under high (H), moderate (M) or low (L) temperatures
95% Confidence
Interval
Variable Temp
Mean
grams
SE
Mean
Lower Upper
Body weight at 42 days of age H 1.792 0.012 1.76 1.82
M 2.032 0.039 1.93 2.13
L 1.693 0.113 1.40 1.98
Haematocrit at 42 days of age H 29.83 0.40 28.8 30.9
M 33 0.816 30.9 35.1
L 34.83 0.401 33.8 35.9
Body temperature at 42 days of age H 42.5 0.289 41.8 43.2
M 42 0.129 41.7 42.3
L 42 0.258 41.3 42.7
4.3.4 Tonic immobility (TI) and plasma corticosterone (CORT) levels
At 21 days (1 day after the initiation of temperature treatment, but prior to IBV challenge) and
41 days of age the birds housed under low and high temperatures had higher TI indices
(p<0.05) than those housed under moderate temperature (Figure 4.10).
At 28 days of age (8 days after the beginning of the temperature treatment), the group of birds
exposed to low temperatures had a significantly higher mean plasma corticosterone
concentration (p<0.05) than birds housed under moderate temperatures (Figure 4.11) (Table
4.2).
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Figure 4.10. Bird in a U-shaped plastic cradle during the TI test
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Figure 4.11.Mean plasma corticosterone concentrations of birds housed under high (■),
moderate (●), or low temperature (■)
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Table 4.2. Confidence intervals for mean plasma levels of corticosterone concentration
(CORT levels) of birds housed under high (H), moderate (M) or low (L) temperatures
95% Confidence
Interval
Variable Temp Mean
SE
Mean
Lower Upper
CORT levels day 6 post challenge H 6.2 1.48 2.34 9.96
M 3.5 0.697 1.54 5.41
L 12.4 2.33 6.38 18.36
CORT levels day 13 post challenge H 3.5 0.52 2.19 4.88
M 2.4 0.85 0.23 4.59
L 2.2 0.48 1 3.46
CORT levels day 20 post challenge H 2.8 0.38 1.84 3.80
M 1.5 0.24 0.86 2.11
L 3.6 1.15 0.67 6.59
4.3.5 Humoral immune response
At one day of age the birds had high titres of maternally-derived antibodies against IBV,
which progressively declined to zero by 22 days of age when IBV was administered
intranasally and SRBC was injected (Figure 4.12). By thirteen days after IBV challenge (35
days of age), the mean antibody titre was lower in birds housed under high (p<0.05)
compared with those under moderate temperatures and there was a tendency for lower
antibody levels in birds housed under low temperatures (Table 4.3).
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Figure 4.12. Antibody titre to IBV measured by ELISA from chickens housed under high (■),
moderate (●), or low temperature (■)
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By six days after SRBC injection (28 days of age) the chickens housed at high temperature
had a significantly higher antibody titre (end point) against SRBC than the birds under low or
moderate temperature (Figure 4.13) (Table 4.3).
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Figure 4.13. Haemagglutinin titre to SRBC of birds housed under high (■), moderate (●), or
low temperature (■)
Table 4.3. Confidence intervals for IBV antibodies and haemagglutinin titres of birds housed
under high (H), moderate (M) or low (L) temperatures
95% Confidence
Interval
Variable Temp Mean
SE
Mean
Lower Upper
Antibodies IBV, day 13 post
challenge (35 days of age)
H 2238 230 1647 2829
M 3440 200 2926 3954
L 2528 230 1937 3119
Antibodies IBV, day 20 post
challenge (42 days of age)
H 2027 274 1323 2731
M 2673 152 2282 3064
L 2708 145 2335 3081
Haemaglutination (SRBC), day 6
post challenge (28 days of age)
H 3.67 0.333 2.81 4.25
M 1.67 0.211 1.12 2.21
L 1.33 0.211 0.79 1.88
Haemaglutination (SRBC), day 13
post challenge (35 days of age)
H 0.83 0.167 0.4 1.26
M 1.08 0.271 0.39 1.78
L 1.67 0.33 0.81 2.25
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4.3.6 Cell mediated immune response
The levels of interferon gamma released by splenic lymphocytes after in vitro stimulation
with IBV antigen tended to be lower in the high and low temperature groups 13 days after
challenge, but the difference was not statistically significant. By twenty days post challenge
the levels of interferon gamma were significantly greater (p<0.05) in the birds housed under
high temperature than in those housed under cold temperature (Figure 4.14) (Table 4.4).
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Figure 4.14. Levels of interferon gamma released from spleen cells stimulated with IBV
antigen and measured by ELISA, from chickens housed under high (■), moderate (●), or low
temperature (■)
Table 4.4. Confidence intervals for INF gamma levels of birds housed under high (H),
moderate (M) or low (L) temperature regimens
95% Confidence
Interval
Variable Temp Mean
SE
Mean
Lower Upper
INF-Gamma, day 13 post
challenge (35 age)
H 0.39 0.183 -0.08 0.86
M 1.73 0.506 0.42 3.03
L 0.79 0.417 -0.29 1.86
INF-Gamma, day 20 post
challenge (42 age)
H 1.23 0.234 0.63 1.83
M 0.77 0.299 0 1.54
L 0.06 0.0291 -0.02 0.13
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4.4. Discussion
The effects of temperature on the manifestation of disease following challenge with IBV (NZ,
strain C) have been demonstrated. It was not possible in this trial to distinguish between
pathology due to temperature differences per se and the effects of temperature plus IBV
infection. However, given the high prevalence of IBV within poultry units of New Zealand
(Lohr, 1974, Ramneek et al, 2005), the effect of environmental temperature on infected birds
is important to note.
When broilers were housed under a moderate environmental temperature, clinical signs were
apparent 2-3 days after infection, peaked at 5-7 days and disappeared within 10-14 days in
agreement with other studies (Hofstad 1984; Dhinakar Raj and Jones 1997; Ramneek 2000).
Low and high temperatures exacerbated the respiratory signs and lesions in birds infected
with IBV.
The increase in mortality of birds subjected to low temperatures resulted from lung oedema,
probably secondary to the pulmonary hypertension syndrome (Cumming 1969; Julian 2005).
It has been reported that low housing temperatures produce changes of osmolarity in the
mucous layer on bronchial walls that can elicit respiratory alterations or pathologies such as
bronchospasm (Gani et al 2003). Furthermore, several birds in the low temperature group
developed ascites, obvious upon necropsy. However, Tottori et al (1997) reported that IBV
may also induce ascites in broilers. In this experiment severe air sac lesions were not found
and this may reflect the mildness of the strain of IBV (Ramneek 2000) or the lack of co-
infections such as Mycoplasma synoviae in the breeding stock (Hopkins and Yoder 1982).
A high proportion of the birds housed under high temperatures showed hepatic lesions,
principally enlarged pale liver with haemorrhages. This is likely to be due to endotoxic shock
due to high temperatures, as described by Crespo and Shivaprasad (2003) and Julian (2005).
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The longer duration of the clinical signs and higher mortality in the birds housed at high or
low temperatures, in comparison with birds under moderate temperature, could be attributed
to lower production of IBV antibody, 2 weeks after infection. Humoral immunity is an
important protective mechanism in the later stages of IB, as shown by Cook et al (1991),
where bursectomised chicks experienced a more severe and longer lasting infection than
intact chicks.
In agreement with previous reports (Vo et al 1978; Cooper and Washburn 1998), the chickens
housed in high temperature showed significantly decreased growth; at the end of the
experiment (day 42), the birds weighed less than those housed at moderate temperatures and
there was a trend for the low temperature birds to have lower body weights. One
interpretation of this is that birds spend more energy on thermoregulation and, thus, have less
available for body growth. It has also been reported that chronic heat exposure significantly
decreases protein digestion (Larbier et al 1993). As feed intakes were not measured,
differences in food conversion efficiencies due to temperature were unknown.
The high temperatures were associated with a reduction in packed cell volume (PCV) (29%
versus 33% in the moderate temperature group), which was similar to results reported by
Luger et al (2001) and likely to be associated with haemodilution, an adaptive response
enabling water loss by evaporation without compromising plasma volume, with most of the
evaporative water loss coming from the extracellular compartment (Darre and Harrison 1987;
Altan et al 2000). The tendency for an increased PCV in birds housed in the cold temperatures
could be caused by a decline in plasma volume as a result of plasma leakage from the blood
vessels as part of the development of ascites or, less likely, by an increase in erythropoiesis as
a compensatory reaction to oxygen lack in the tissues or to the high levels of corticosterone
(Luger et al 2003).
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The specific antibody response to IBV was measured using an indirect ELISA method with
the VicS IBV strain as capture antigen - previously shown to crossreact with all NZ strains
(Ramneek 2000). The antibody response (presumably a mixture of IgM and IgG and
predominantly the latter) was significantly reduced in birds housed under high temperatures,
in agreement with Zulkifli et al (2000) and Mashaly et al (2004), who showed that heat-stress
caused a reduction in antibody synthesis in vivo to Newcastle Disease Virus and SRBC. Wang
et al (2001) reported that acute heat stress decreased the release of T-helper 2 cytokines in
rats, which are important for antibody production (Lebman and Coffman 1998). Mujahid et al
(2005) reported that heat stress in chickens stimulates free oxygen radical production, which
is known to have several non-specific damaging effects on the immune system. Perhaps, the
requirement for nutrients to maintain an efficient immune response was not met in the current
experiment due to a reduction in feed intake (not measured in this trial) plus low feed
digestibility (proteins, fat, starch), that occurs in birds under heat stress (Bonnet et al 1997).
In the present study, low temperatures tended to reduce IBV titres in peripheral blood but this
was not significant. Hangalapura et al (2004a) reported that cold stress (10
o
C, a similar
temperature to that used in the present experiment) did not affect specific antibody response
to keyhole limpet haemocyanin (KLH). However, Hester et al (1996) reported that a short
exposure to 0
o
C decreased antibody response of single caged hens but not of hens in colony
cages, presumably indicating the thermal advantage of collective huddling. Parmentier et al
(2002) and Svensson et al (1998) reported a low energy requirement for the humoral immune
response in poultry. In the present experiment there was an unlimited supply of feed and so
the birds in low temperatures may have met the energetic requirements of immunity and
growth by increasing food intake to avoid any trade-off between these demands and demands
for other needs such as growth.
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As compared to the above results, the birds housed at high temperatures developed
significantly higher levels of haemaglutinating antibodies to SRBC than birds housed under
low or moderated temperatures, 6 days after injection (28 days of age). This response was
similar to that observed by Heller et al (1979) who reported that chickens (Rhode Island Red
x Leghorn) housed at 41.5+/- 1
o
C had an enhanced humoral response to SRBC when there
was a time-lapse of 24 to 96 hours between immunisation and heat exposure (a time-lapse of
less than 24 hours did not have any effect). Furthermore, Regnier et al (1980) reported that
New Hampshire birds, housed for 5 days at 36
o
C and inoculated intravenously with SRBC 24
hours before thermal treatments, had higher titres to SRBC 10 days after vaccination.
Similarly, with cold stress of chickens there was an increase in immune response, measured as
increased IgM antibody production and a markedly reduced the IgG antibody titre (Subba Rao
and Glick 1977).
It has been reported that mild stress or relatively brief stress responses can enhance certain
immune responses including innate (Brines et al 1996), humoral (Grayson et al 1981; Cupps
et al 1985), and cell mediated immunity (Wiegers et al 1993). However, heat stress has also
been reported to cause immunosuppression in commercial layers, housed at (35
o
C for 5
weeks, Mashalay et al 2004) or to have no immunological effect at all (36
o
C for 5 days;
Regnier et al 1980). The differences in the humoral responses to IBV and SRBC may be
explained by the fact that the haemagglutination test principally detects the levels of IgM in
response to a challenge with SRBC and the IBV ELISA used in this experiment measures
both the levels of IgM and IgG (but predominantly the latter), 6 weeks after infection.
As in mammalian systems, studies in poultry have shown that the measurement of chicken
interferon gamma released by T cells after in vitro stimulation gives a good evaluation of
CMI (Prowse and Pallister 1989; Lambrecht et al 2004), which is a major protective
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mechanism against IBV (Seo and Collisson 1997). Cell mediated immunity was not
significantly affected by heat stress or cold stress in the first 13 days of treatment with a
tendency to be less but at 20 days the levels of interferon gamma in the birds subjected to low
temperatures were lower than in the high temperature group. These results extend those of
Mashaly et al (2004) who showed that non-specificT cell activities (mitogen proliferation
assay) of chickens one week after heat exposure were not significantly affected by heat stress,
and Regnier and Kelly (1981) who also reported that low temperatures suppressed non-
specific cell mediated immune responses (measured by phytohaemagglutinin skin test) after 5
days of exposure at 1
o
C. Hangalapura et al (2004a) reported that low temperatures can
enhance cell mediated immune response (lymphocyte proliferation). In mice, Iwakabe et al
(1998) reported that NK activity and IFN-γ production from cultured spleen cells was greatly
reduced when the animals were under stress (physical restraint).
Interpretation of the difference in the immune response to high or low temperatures between
different studies is complicated by the nature and duration of the stressor [10oC in the present
experiment and with Hangalapura et al (2004a) versus 0
o
C in the trial by Hester et al (1996)],
difference between lines of chickens [Cobb broilers in this trial versus commercial layers with
Mashalay et al (2004)] and immunological parameters under investigation [IFN-γ production
in the present experiment versus lymphocyte proliferation with Hangalapura et al (2004a)].
The birds housed in low and high temperature had a longer tonic immobility period, in
accordance with previous findings from Altan et al (2003), but in contrast to other reports
where no effect followed housing at 36
o
C for 6 hours (Zulkifli et al 1999).
It was found that only the birds housed under low temperatures had a peak of plasma
corticosterone concentration (one week after the start of treatment) in agreement with Luger et
al (2003) (broilers), but in conflict with a report by Hangalapura et al (2004b) who showed
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that low temperature decreased plasma corticosterone levels in layer birds. In general, plasma
corticosterone concentrations decreased after the peak (one week after treatment), which
could reflect adaptive mechanisms (Post et al 2003) such as changes in the level of plasma
corticosteroid binding protein (Turner 1986).
The immunosuppressive effects of stress have been hypothesed to be via the production of
glucocorticoids despite the fact that some researchers have demonstrated that stress-induced
suppression of immunity can be produced in an adrenal-independent manner, suggesting that
a variety of other hormones, neurosecretory products and cytokines may be involved (Keller
et al 1983; Bonneau et al 1993. In this trial levels of corticosterone were not associated with
immune response; that is the corticosterone peak in the cold treatment group,1 week after
challenge, was not associated with immunosuppression or enhancement.
In conclusion, the clinical signs and lesions produced by IBV were exacerbated under
extremes of temperature. This is the first study to show the effect of temperature on the
immune response to IBV in broilers. Cell mediated (INF γ) and humoral (antibody) immunity
to IBV was affected by housing temperature. The increased tonic immobility period and
levels of corticosterone in chickens were also linked to house temperature and indicate
welfare concerns. There was no evidence linking the levels of corticosterone to
immunosuppression in birds housed at high or low temperatures. The cost that the broilers
have to pay in order to retain or regain homeostasis is important from both immunological
and production points of view. More specific experiments are needed to better characterise the
mechanisms that modulate immune function during stressful episodes.
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Chapter 5
EFFECT OF CORTICOSTERONE ON THE IMMUNE RESPONSE IN BROILER
CHICKENS
5.1 Introduction
From the time chicks are hatched and throughout the rest of their lives, different stressors
confront them. The physiological regulation of homeostasis is achieved by complex endocrine
interactions, principally by the hormones secreted from the adrenal gland (Harvey et al 1984).
Different forms of stress are directly or indirectly translated to the body by two commonly
used endocrine pathways (Post et al 2003). These two arms of the stress response consist of
the sympathetic-adrenalmedullary axis, resulting in the release of catecholamines, and the
limbic-hypothalamo-pituitary-adrenocortical axis, which causes the release of
glucocorticoids. Several studies have pointed out that neuro-endocrine-immune interactions
may affect the immune response (Savino and Dardenne 1995; Cohen et al 1999). It has been
reported in several animal species that hormones secreted during a stress response can
produce either stimulatory or inhibitory effects, depending on the nature and duration of the
stressor and the immunological parameter under investigation (Sapolsky et al 2000; Pruett
2001).
Corticosterone (CORT) is the principal glucocorticoid released by adrenal glands in birds in
response to hypothalamic-pituitary activity (Harvey et al 1984). Its physiological function is
in restraining the defence reactions to stress, which would themselves become damaging if
left uncontrolled (Munck et al 1984) and it redirects metabolism tomeet the energy demands
during stress (Ingle 1954). CORT released by the adrenal gland in response to a stressful
situation is mostly transported bound to plasma proteins (Carsia and Harvey 2000), but the
free (i.e. non-protein bound) moiety passes readily from the circulation through the plasma
membrane of cells eventually to reach specific nuclear receptors namely the mineralocorticoid
65
receptors (MRs) and glucocorticoid receptors (GRs) (Carsia and Harvey 2000). Unliganded
GRs and MRs exist as monomers in a multiprotein complex with several chaperones, such as
heat-shock proteins and immunophilins (Bamberger et al 1996). The hormone-receptor
complex translocates to the nucleus, and after forming homo or heterodimers or associating
with other proteins (Bamberger et al 1996), initiates either the activation or suppression of
specific genes (Boumpas et al 1993).
Most organs and physiological systems in birds have cells with receptors that are responsive
to CORT including the brain (Koehler and Moscona 1975), thymus (Gould and Siegel 1984),
Bursa of Fabricius (Sullivan and Wira 1979) and liver (Tu and Moudrianakis 1973). It has
been reported that long exposure to CORT produces metabolic and behavioural changes in
birds. These included decreases in growth and body weight (Hayashi et al 1994; El-Lethey et
al 2001), atrophy of lymphoid organs (Dohms and Metz 1991), increased fat deposition,
largely in the abdomen and liver (Saadoun et al 1987) and increased tonic immobility (TI)
duration (Jones et al 1988; El-Lethey et al 2003).
The involvement of endogenous glucocorticoids in the host's defence against infection has
been highlighted by studies with adrenalectomised animals. In those studies, increased
mortality was found in adrenalectomised animals after injection with E. Coli, bacterial
lipopolysaccharide, IL-1β, or TNF-α; this increased mortality was essentially eliminated by
administering exogenous glucocorticoids to adrenalectomized animals prior to challenge
(Bertini et al 1988; Gonzales et al 1993; Kapcala et al 1995)
Numerous studies (Griffin 1989; Sapolsky et al 2000; Isobe and Lillehoj, 1992, 1993) have
shown that pharmacological doses of CORT can inhibit the production of many cytokines,
e.g. IL-1, IL-2, IL-3, IL-5, IL-6, IL-8, IL-12, interferon γ (IFN-γ), tumour necrosis factor α
(TNF-α), granulocyte–macrophage colony-stimulating factor (GM-CSF), by suppressing
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transcription, translation, and secretion or by destabilizing its mRNA (Knudsen et al 1987;
Wiegers and Reul 1998) or by inducing a decoy receptor that binds and sequesters without
transmitting any activity (Colotta et al 1993). Surprisingly, glucocorticoids given at high
doses in vitro have been shown to up-regulate the expression of various cytokine receptors,
which is in apparent contrast to the other ‘restraining’ effects of these hormones: e.g. for IFN-
γ (Strickland et al 1986), IL-2 (Fernandez-Ruiz et al 1989) and IL-6 (Campos et al 1993).
Furthermore, it has been reported that eosinophils cultured in vitro express increased levels of
major histocompatibility complex (MHC) class II molecules in the presence of
glucocorticoids and either IL-3, IL-5 or GM-CSF, leading to enhanced antigen presentation
(Guida et al 1984). This paradox (inhibition vs enhancement) is not well understood in terms
of its molecular mechanism or physiological significance (Wiegers and Reul 1998). It has
been assumed that the factors which alter the balance between inhibition and enhancement are
the amount of corticosterone released and/or the duration of the stress situation (Davis et al
1997; Dhabhar 2002).
The goal of this study was to assess the effect of stress (as mimicked by the administration of
physiological doses of CORT), on both humoral and cell-mediated immune responses in
chickens challenged with infectious bronchitis virus (IBV), and injected with sheep red blood
cells (SRBC) and phytohaemagglutinin (PHA).
5.2 Materials and methods
5.2.1 Titration of oral corticosterone treatment
In order to establish the appropriate quantity of CORT required to changen immune function
and track the pharmacokinetics of CORT in 20 day-old commercial broilers, a pilot trial was
carried out. Two different doses of CORT (Sigma Chemical Co, USA) were administered via
the drinking water (15.4mg/l and 7.7mg/l) to two groups and a third untreated group was a
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control (all, n=8). All the birds were injected in the breast muscle with SRBC [0.5 ml of
packed sheep red blood cells (50% v/v in PBS)] two days after the start the treatment with
CORT (day 22 of age). At 6 and 10 days post vaccination with SRBC serum was collected
and the anti-SRBC antibody titre was assessed by haemagglutination test (1:2 dilution), as
described by Wegmann and Smithies (1966).
5.2.2 Animals, housing conditions and corticosterone treatment
In the main trial, one hundred day-old broiler chickens (Cobb breed) were obtained from a
commercial hatchery. The birds were housed under a controlled environment, placed in cages
and fed ad libitum from the day of hatching until they were 42-day-old. They were subjected
to decreasing light and temperature as outlined in Chapter 4.
At 22 days of age the birds were weighed and randomly divided in three equal groups (33
birds per group), housed at 20-21
o
C and provided with eight hours of continuous light until 42
days of age.
The first group was the control [not challenged with infectious bronchitis virus (IBV) and not
treated with CORT], the second group was not exposed to exogenous CORT but was
challenged with IBV. The third group was treated via the drinking water with CORT (15.4
mg/l; Sigma Chemical Co, USA) from day 22 until the day 42 of age and challenged with
IBV (Figure 5.1). Treatment groups were segregated in separate isolation rooms with separate
air sources and sanitary procedures.
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Figure 5.1. Experimental design to test the effect of corticosterone on the immune response in
broiler chickens
5.2.3 Infection and immunization
At 27 days of age (5 days after the CORT treatment started) the birds from the second and
third group were infected intranasally with IBV (100 µl of 10
6
ELD50/ml, NZ strain C) and
were injected in the right breast muscle with SRBC [0.5 ml of packed sheep red blood cells
(50% v/v in PBS)]. Groups of birds were euthanased (cervical dislocation), weighed and
necropsies were performed at a number of different time points (22, 27, 34 and 42 days of
age).
All experimental procedures were conducted in accordance with the requirements of the
Lincoln University Animal Ethics Committee.
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5.2.4 Clinical signs
For each group, respiratory signs were visually scored (number of birds showing that
particular sign) three times a day, using a modification of the method described by
Avellaneda et al (1994), as described in Chapter 4. Scores were pooled within groups, and the
final score was the mean of the scores on that day.
5.2.5 Lesions
The number of dead birds was recorded daily. Gross lesions in both the dead and euthanased
birds (on days 22, 27, 34 and 42 of age) were evaluated following necropsy, using a
modification of Avellaneda et al (1994) (liver lesions), Kleven et al (1972) (air-sac lesions),
Balog et al (2003) (heart lesions), as described in Chapter 4.
5.2.6 Relative spleen weights
At 42 days of age six birds from each group were euthanasied (by cervical dislocation) and
weighed. The ratio (%) between spleen and body weight was calculated (organ weight/body
weight x 100).
5.2.7 Tonic immobility (TI)
The time lag between the removal of restraint and the righting response was assessed twice at
23 and 41 days of age. Tonic immobility was achieved by placing birds in a supine position in
a U-shaped plastic cradle covered with a cloth and restraining them for 15 seconds, as per
Jones and Faure (1981). The time until a full righting response was recorded. Failure to obtain
a TI reaction lasting at least 10 seconds resulted in exclusion of the bird from the analysis.
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5.2.8 Plasma corticosterone concentration
At 22, 27, 34 and 42 days of age, blood samples (1 ml) were taken from the brachial (wing)
vein of 6 birds per treated group, into tubes containing heparin, within three minutes of
capture. Samples were centrifuged at 2,300 rpm for 10 minutes, the plasma aspirated and
stored at -70
o
C. Plasma CORT concentration was measured by radioimmunoassay (RIA), at
the Institute of Veterinary, Animal and Biomedical Sciences, Massey University, NZ (Littin
and Cockrem 2001).
5.2.9 Determination of antibody titres
Blood samples (1 ml) were collected from the brachial vein, at 1, 14, 22, 27, 34 and 42 days
of age to measure serum antibody levels against IBV and/or SRBC. Antibody production
against sheep red blood cells SRBC was measured using a haemagglutination test as
described by Wegmann and Smithies (1966). Antibody titres to IBV were determined by
Tegel Foods Ltd, New Plymouth, using a commercially available ELISA kit (TropBio Pty
Ltd, Queensland, Australia) containing the Vic S strain of IBV, as per Chapter 4.
5.2.10 Interferon gamma
Six birds from each of the three groups were slaughtered on days 22, 27, 34, and 42 in order
to assess the levels of interferon gamma (IFN γ) produced by splenic lymphocytes cultured in
vitro (Lambrecht et al 2000), as per Chapter 4.
5.2.11 Intradermal hypersensitivity
At 40 days of age the birds from the second and third groups were injected in the right wattle
with 200 µg of phytohaemagglutinin (PHA) in 0.1 ml of sterile pyrogen-free physiologic
saline solution as described by El-Lethey et al (2003). The left wattle was injected with saline
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solution as a control. The wattle thickness of each bird was measured with a dial micrometer
(Combiice, Mitutoyo, Japan) 24 h later, as described by Tella et al (2002). The response was
recorded in millimeters as the difference between the PHA response (right wattle) and the
saline response (left wattle), 24 h after injection. 
5.2.12 Statistical analysis
For relative spleen weights, antibody levels, IFN γ production, PHA skin reaction, TI and
CORT concentrations, treatments were compared by one way ANOVA using MINITAB
Statistical Software (Minitab Inc, USA). Where the ANOVA F test was significant across all
treatments, differences between the means were determined using the value of the Least
Significant Difference (LSD), where LSD equals smallest difference between two means that
could be deemed as significant. Assessment of independence between discrete variables
(number of birds showing clinical signs and lesions) was carried out using Fisher’s exact test.
5.3 Results
5.3.1 Dose effect of corticosterone (pilot trial)
Plasma CORT concentration peaked after 2 days of ingestion and then decreased (Figure 5.2).
0
5
10
15
20
25
30
35
Day 1 Day 3 Day 8 Day 15
Days of treatment
n
g
/m
l
Figure 5.2. Plasma CORT concentrations in chickens untreated (■) or treated with CORT via
the drinking water at 15.4mg/l (■) or 7.7mg/l (□)
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Both CORT treatments (15.4mg/l and 7.7mg/l) produced significant immunodepression
(p<0.001) in comparison with the untreated birds, as reflected in the lower production of
haemagglutinating antibodies (Figure 5.3).
Figure 5.3. Haemagglutinin titre to SRBC measured in birds treated with 15.4 mg/l of CORT
(■), 7.7 mg/l of CORT (□) or untreated (■)
5.3.2 Clinical signs
In the main trial there was no effect of corticosterone treatment on the proportion of IBV-
challenged birds showing clinical signs (Figure 5.4), although there was a tendency for the
clinical signs to persist with CORT treatment.
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Figure 5.4.Mean clinical score (0-3) of birds under CORT treatment and challenged with
IBV (■), untreated with CORT and challenged with IBV (▲), and control (untreated with
CORT and no challenge) (○)
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5.3.3 Lesions
After 5 and 13 days the CORT treated birds had more hepatic alterations (e.g., enlarged with
rounded borders,, fatty infiltration) than untreated birds (p = 0.061 and 0.002, respectively)
(Figure 5.5). The CORT treated birds had an increase of intra-abdominal fat (Figure 5.6).
Figure 5.5. (a) Fatty and enlarged liver from a bird under CORT treatment, (b) liver from an
untreated bird
Figure 5.6. Large accumulation of fat in the abdominal cavity of a CORT- treated bird
a b
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5.3.4 Body weight and relative spleen weights
At 42 days of age the CORT treated birds had significantly lower body and relative spleen
weights (p<0.01) than untreated birds (Figure 5.7) (Appendix V)
Figure 5.7. (a) Spleen from an untreated bird, (b) spleen from a bird treated with CORT for
22 days. Graduation from 2-3 mls equates to 7 mm)
Table 5.1. Statistical differences between relative spleen weights (grams)
(at 42 days of age), determined by LSD. Different letters indicate p<0.05
Mean
Control group 0.09 b
Group of birds challenged but not
treated with CORT
0.08 b
Group of birds challenged and
treated with CORT 0.05 a
LSD 5%
F test
0.02
p<0.01
a b
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5.3.5 Tonic immobility (TI) and plasma CORT concentration
At 23 days of age (first day of CORT treatment) there were no differences in TI indices
between the three groups, but at 41 days of age the birds under CORT treatment (for 19 days)
had higher TI indices (p<0.05) than the untreated birds (Table 5.2).
Table 5.2. Statistical differences between the means of TI (41 days of age), as determined by
LSD. Different letters indicate p<0.05
Mean
Control group 273 a
Group of birds challenged but not treated
with CORT
353 a
Group of birds challenged and
treated with CORT
673 b
LSD 5% 146
F test P<0.001
At 34 and 42 days of age, the group of birds treated with CORT had a significantly higher
mean of plasma corticosterone concentration (p<0.05) than birds not treated with CORT
(Figure 5.8).
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Figure 5.8.Mean plasma levels of corticosterone concentrations of chickens treated with
CORT and challenged (■), untreated with CORT but challenged with IBV (▲), and controls
(○), untreated with CORT and not challenged with IBV.
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5.3.6 Humoral immune response
At day 1 of age the birds had a high titre of antibodies against IBV (data not shown), which
progressively declined to zero at 27 days when IBV was administered intranasally and SRBC
were injected. Following IBV challenge (from 27 to 42 days of age) the birds under CORT
treatment showed a significant (p<0.001) increase in antibody titre against IBV in comparison
to the birds not treated with CORT (Figure 5.9).
Figure 5.9. Antibody titre to IBV measured by ELISA from chickens challenged with IBV
and either treated with CORT (■), or not treated with CORT (▲), or were controls - neither
challenged with IBV nor treated with CORT (○)
Table 5.3. Statistical differences between the increase of antibody titre to IBV (day 27 to 42
of age), determined by LSD. Different letters indicate p<0.05
Mean
Control group -87 a
IBV challenged but not
treated with CORT
2261 b
IBV challenged and treated
with CORT
2671 c
LSD 5% 257
P value <0.001
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At day 7 after challenge (34 days of age) the chickens under CORT treatment had a
significantly higher antibody titre against SRBC than the birds not treated with CORT (Figure
5.10) (Table 5.4).
Figure 5.10. Haemagglutinin titres to SRBC measured in birds under CORT treatment and
injected with SRBC (■), not treated with CORT and injected with SRBC (▲), and controls (○)
neither treated with CORT nor SRBC
Table 5.4. Statistical differences between the means of haemagglutinin titres to SRBC (eight
days post challenge), as determined by LSD. Different letters indicate p<0.05
Mean
SRBC injected but not
treated with CORT
2 a
SRBC injected and treated
with CORT 5.3 b
LSD 5% 1.88
P value p=0.003
5.3.7 Cell mediated immune response
The levels of IFNγ released by splenic lymphocytes after in vitro stimulation with IBV
antigen were higher in the CORT treated group seven days after challenge (p<0.001) in
comparison with birds not treated with CORT but infected with IBV. Fifteen days after IBV
78
challenge the levels of IFNγ were significantly greater (p<0.05) in the birds not treated with
CORT compared with those treated with CORT (Figure 5.11) (Table 5.5).
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Figure 5.11. Levels of IFNγ (as optical density units) released from spleen cells stimulated
with IBV antigen and measured by ELISA, from chickens treated with CORT (■), untreated
with CORT (▲), and control (○) – neither treated with IBV nor CORT
Table 5.5. Statistical differences between the mean levels of IFNγ released from spleen cells
stimulated with IBV antigen and measured by ELISA (OD) (7 and 15 days post challenge), as
determined by LSD. Different letters indicate p<0.05
Mean at 34 days of age
(7 days post challenge)
Control group 0.20 a
IBV challenged but not
treated with CORT
0.76 b
IBV challenged and treated
with CORT
1.22 c
LSD 5% 0.41
F test p<0.001
Mean at 42 days of age
(15 days post challenge)
Control group 0.16 a
IBV challenged but not
treated with CORT
0.61 b
IBV challenged and treated
with CORT
0.17 a
LSD 5% 0.03
F test p<0.001
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The elicited skin reaction to PHA showed that the birds treated with CORT had a significantly
smaller (p<0.001) reaction (right wattle) (Figure 5.12) (Table 5.6), compared with the control
(PBS), irrespective of IBV challenge.
…
Figure 5.12. Reaction to PHA injection (right wattle) of birds not treated with CORT (a, b),
as compared to a bird treated with CORT (c)
Table 5.6. Statistical differences between the means of the PHA reaction (mm), as determined
by LSD. Different letters indicate p<0.05
Mean LSD 5% P value
Control group 3.47 b
IBV challenged but not
treated with CORT
3.39 b
IBV challenged and treated
with CORT
1.94 a
0.72 p<0.001
5.4 Discussion
It has been reported that certain stressors can enhance or suppress the immune response in
birds, for example, feed restriction (Hangalapura et al 2005), high temperatures (Heller et al
1979; Regnier et al 1981), low temperatures (Subba Rao and Glick 1977; Hangalapura et al
2003) and it is assumed that these changes are attributable to CORT released by the adrenal
gland in response to the stress. Adrenalectomy eliminates such stress-induced changes
(Dhabhar 2003). In this trial, the oral administration of low physiological doses of oral
a b c
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corticosterone, as compared to higher parenteral pharmacological doses administered in most
research trials [(680 micrograms/kg body weight per day, Bartov (1982)], was an attempt to
mimic a period of protracted stress. It was important to produce a level of CORT in the serum
(>8ng/ml),similar to that found during hypothermic conditions in a previous experiment
(Chapter 4).
To our knowledge, this is the first study showing that low levels of exogenous CORT can
produce an enhancement in the immune response of chickens. The humoral response to IBV
(2 weeks post-challenge) and SRBC in vivo and the production of INFγ in vitro (1 week post-
challenge) was enhanced in birds treated with CORT, in comparison to the control group.
Previous studies have highlighted either the general immunosuppressive effects of CORT in
birds (El-Lethey et al 2003; Post et al 2003) or lack of effect (Donker and Beuving 1989).
However, in this trial the birds treated with CORT showed a decreased skin reaction to PHA
in agreement with other studies (El-Lethey et al 2003; Corrier et al 1990). This contradictory
response: enhancement (IFN γ and IBV antibodies) and depression (PHA) of immunity could
be attributable to the different responses generated. That is, a highly specific recall response
(acquired) to an endemic pathogen such as IBV versus a non-specific, primary, response to
injected PHA.
It is likely that the effects of CORT on the immune response depend on how it was
administered, the amount administered, the temporal association between administration of
the glucocorticoid and exposure to other environmental insults and the duration of the CORT
treatment (Pruett et al 1993; Hangalapura et al 2004b). For example, birds injected with
SRBC three days after the start of treatment with corticosterone showed immunodepression
(Post et al 2003), but a stress situation (high temperature) occuring later after challenge,
enhanced the immune response (Heller et al 1979; Regnier et al 1981).
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In the present trials, utilizing the same method of CORT administration and antigen (SRBC)
challenge there was an obvious immunological difference that depended on timing or dose. In
the pilot trial, the humoral response to injected SRBC was depressed when the birds had two
days prior exposure to exogenous corticosterone. However, when the birds had five days prior
exposure there was immune enhancement to both test antigens (SRBC and IBV) given by
different routes (intramuscular injection and intranasal aerosol, respectively). It should be
noted that in the pilot trial plasma CORT concentration was shown to be very high at the
moment of challenge (Figure 5.2) [26.7ng/ml (birds drinking 15.4 mg/l) and 18.7 ng/ml (birds
drinking 7.7 mg/l)] then it decreased to 5.6 ng/ml (birds drinking 15.4 mg/l) and 4 ng/ml
(birds drinking 7.7 mg/l), after fifteen days of oral administration. In the study where Post et
al (2003) described immunodepression the level of CORT in plasma was also very high at the
moment of challenge [35 ng/ml (birds drinking 20 mg CORT/l)]. The lower levels of plasma
CORT concentration at the moment of the challenge in the main experiment (4.14 ng/ml)
could have acted as booster to the immune response as regular mild stress such as moderate
intensity exercise has been associated with reduced severity of infections and improved
antibody responses in mice (Cannon and Kluger 1984). In contrast, a single and strenuous
exercise event has been linked to increased susceptibility to infection and reduced immune
functions (Davis et al 1997).
Alternatively, the interval between administration of CORT and challenge with antigen (2
days in pilot trial versus 5 days in the main trial) may have been critical to directing
immunocompetency. It has been reported that exposure of humans to cortisol for up to a week
before challenge with endotoxin enhances TNF-α and IL-6 levels, whereas cortisol at the time
of or after endotoxin suppresses the cytokine response (Barber et al 1993). The resultant
levels of plasma cortisol achieved in that study at the time of endotoxin challenge, were
unknown. The reason why the body responds to a mild stress or low levels of corticosterone
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producing enhancement of the immune function may have some ‘survival logic’given that one
of the primary functions of the brain is to perceive stressors, warn of danger and enable an
organism to deal with the consequences (Dhabhar 2002). If a bird sees a predator it is
expected that in tandem with the preparation to fight or flight, a response of
immunoenhancement rather than immunosuppression would be adaptive since wounding and
infection are often the results of aggressive encounters in nature (Dhabhar 2002).
The initial place for replication of IBV in the respiratory tract occurs in the epithelial cells of
the trachea (Dhinakar Raj and Jones 1997), subsequently a viremia occurs and the virus gets
widely circulated to other tissues (McMartin 1993). In this experiment CORT treatment did
not affect clinical outcome as measured by respiratory signs. This, despite the enhanced IBV
titres and IFN-γ (in vitro) production in the CORT-treated birds at 35 and 42 days of age,
respectively.
In the current trial, the birds that drank CORT for 20 days had lower body weights and lower
relative spleen weights than the birds not treated with CORT. This is in accordance with
previous reports in which significantly lower body weights were observed in CORT-treated
birds (Hayashi et al 1994; El-Lethey et al 2001; Post et al 2003). The decrease in body weight
was associated with reduced muscle mass and was likely to be due to an increase in net
muscle protein catabolism (Hayashi et al 1994) or CORT-impaired insulin signalling in the
liver and muscle (Dupont et al 1999). Dohms and Metz (1991) and Post et al (2003) reported
that CORT treatment of chickens caused splenic atrophy due to lymphoid depletion of the
white pulp.
In the present trial the birds under CORT treatment had enlarged fatty livers, attributable to
disturbances in lipid metabolism (lipogenesis) in the liver (Puvadolpirod and Thaxton 2000;
Post et al 2003; Saadoun et al 1987). In addition, the CORT-treated birds had larger fat
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deposits in the abdomen which has also been reported by other authors (Saadoun et al 1987;
Hayashi et al 1994), and is due to the hyperlipaemic effect of the hormone.
Infection with IBV generated an enhanced fear response as measured by TI highlighting the
affect of this disease on a chicken’s ‘wellbeing’. This was significantly increased when IBV-
infected birds were treated with CORT indicating the role of the latter, as has been reported
by Jones et al (1988) and El-Lethey et al (2003).
In conclusion, the ingestion of low physiological amounts of CORT alters immunity to, and
disease outcome from, infections with IBV. While the hormone appeared to exaggerate the
effects of IBV (righting reflex and a tendency for increased clinical signs), certain immune
functions were enhanced. The response to particulate antigen (SRBC) varied between the 2
different trials which were carried out at different times and with minor differences in
management. Thus, a further experiment to test the affect of the duration of administration of
exogenous CORT on the immune system was undertaken to clarify this point.
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Chapter 6
EFFECTS OF CORTICOSTERONE ON THE IMMUNE RESPONSE IN CHICKENS
DEPEND ON DURATION OF ACTION
6.1 Introduction
Current concepts on the role of glucocorticoids such as corticosterone (CORT) in the
regulation of inflammatory and immune responses indicate that their role is inhibitory
(Wiegers and Reul 1998). However, a large number of studies (e.g., rats, human) have also
shown that glucocorticoids exert stimulatory effects on immune function, suggesting that the
present concept of the role of glucocorticoids in the immune system is incomplete and needs
to be extended (Wiegers and Reul 1998, Sapolsky et al 2000). It is believed that one factor
influencing the balance between inhibition or enhancement is the amount of corticosterone
produced by a stressor and/or its duration (Davis et al 1997). It has also been proposed that
the time between the release or exposure to CORT and the timing of the challenge can change
the immune response (towards inhibition or enhancement) (Dhabhar 2002). For example,
exposure of humans to cortisol for up to a week before challenge with endotoxin enhances
TNF-α and IL-6 levels, whereas cortisol given at the time of, or after, endotoxin suppresses
the cytokine response (Barber et al 1993). In rats, pre-exposure to CORT in vivo or in vitro
enhanced mitogenesis of rat splenic lymphocyte mitogenesis after short term pre-exposure to
corticosteroid in vitro (Wiegers et al 1993; Wiegers et al 1994). In chickens it has been
reported that CORT added to feed or water 1 or 2 days before immunization decreases
humoral immunity (Gross et al 1980; Post et al 2003). In a previous experiment (Chapter 4),
we have shown that a combination of low temperature and IBV infection caused a significant
increase of serum CORT. In addition, we have found that birds exposed for 5 days to
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physiological levels of CORT before challenge had an enhanced immune response (Chapter
5).
It was therefore hypothesized that the effect of CORT on immune response may depend on
the duration of the stress event. In the present experiment, the duration of the stress was to be
mimicked by the oral administration of CORT given at different time points and relevant
immune responses to antigens assessed.
6.2 Materials and Methods
6.2.1 Animals and housing conditions
Two hundred day-old broiler chickens (Cobb breed) were obtained from a commercial
hatchery. The birds were placed in cages and provided with ad libitum access to a commercial
ration and drinking water until 50 days of age when the trial was terminated. For the first 3
weeks of age the birds had the same light and temperature programme as in Chapter 4; a
decreasing light schedule of (23h→ 16h per day), and temperature (30
o
C→ 20
o
C). At 23
days of age the birds were randomly assigned to one of four treatment groups (n=50): group 1
[not challenged with IBV but treated with CORT (14.7 mg/l) in the drinking water from day
23], group 2 [challenged with IBV, injected with SRBC and PHA but not treated with CORT],
group 3 [challenged with IBV, injected with SRBC and PHA and exposed to CORT (14.7
mg/l) from the day 23 of age (5 days before challenge)], and group 4 [challenged with IBV,
injected with SRBC and PHA and exposed to CORT (14.7 mg/l) from day 26 of age (2 days
before challenge)], (Figure 6.1). Each treatment group was housed in isolated rooms with
separate air, food and water sources.
86
6.2.2 Experimental infection, immunization and blood sampling
At 28 days of age all birds in groups 2, 3 and 4 were infected (challenged) intranasally with
100 µl of 10
6
EID50/ml of IBV (NZ strain C). At the same time, 0.5 ml of packed sheep red
blood cells (50% v/v in PBS) was injected into the right breast muscle of all birds in groups 2,
3 and 4. Additionally, at 45 days of age, 8 birds from groups 2, 3 and 4 were injected in the
right wattle with 200 µg of PHA in 0.1 ml of sterile pyrogen-free physiological saline
solution, while the left wattle was injected with saline as a control. The wattle thickness of
each bird was measured with a dial micrometer (Combiice, Mitutoyo, Japan) 24 h later, as
described by Tella et al (2002). The response was recorded (mm) as the difference between
PHA response (right wattle) and the saline response (left wattle) as described in Chapter 5.
Blood samples (1 ml) were collected from the brachial vein within 3 minutes of capture at 14,
23, 28, 36 and 43 days of age. Samples were centrifuged at 2,300 rpm for 10 minutes and the
plasma and serum aspirated and stored at -70
o
C (Figure 6.1).
All experimental procedures were conducted in accordance with the requirements of Lincoln
University Animal Ethics Committee.
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Figure 6.1. Experimental design to test the effects of corticosterone on the immune response
in chickens
6.2.3 Clinical signs and lesions
The methodology used for the evaluation of the clinical signs and lesions was the same as that
described in the Chapter 4 and 5 and as described by Avellaneda et al (1994), with some
modifications (scores 0-3 instead of 1-4).
The air-sacs lesions were scored as described by Kleven et al (1972), liver lesions as
described by Avellaneda et al (1994), and heart lesions as described by Balog et al (2003),
with modifications as outlined in Chapter 5.
At slaughter (50 days of age) body and spleen weights were measured and relative spleen
weights calculated (spleen/body weight x 100).
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6.2.4 Tonic immobility (TI)
The righting response was assessed twice, at 22 and 49 days of age. Tonic immobility was
achieved by placing birds in a supine position, in a U-shaped plastic cradle, covered with a
towel, as described in the Chapter 5.
6.2.5 Corticosterone levels in drinking water and plasma
The CORT levels were measured by radioimmunoassay (RIA), at the Institute of Veterinary,
Animal and Biomedical Sciences, Massey University, NZ (Littin and Cockrem 2001).
6.2.6 Determination of antibody titres
Antibody (IgG) titres to IBV were measured from blood serum were collected on days 1, 14,
23, 28, 36, 43, and 50 of age by Tegel Foods Ltd, New Plymouth, using a commercially
available ELISA kit (TropBio Pty Ltd, Queensland, Australia), containing the IBV Vic S
strain as capture antigen. Antibody production against SRBC was measured using a micro-
haemagglutination test (1:2 dilution), as described by Wegmann and Smithies (1966) and
results were expressed as the reciprocal of the highest dilution of serum showing specific
agglutination with antigen.
6.2.7 Interferon gamma (INFγ)
Twelve birds from each of the four groups were slaughtered on days 23, 28, 36, and 43 in
order to assess the levels of INFγ produced by splenic lymphocytes cultured in vitro
(Lambrecht et al 2000), as per Chapter 4.
6.2.8 Statistical analysis
Assessment of independence between discrete variables (number of birds showing clinical
signs and lesions) was carried out using Fisher’s exact test (2 x 2 table).
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Relative spleen weights, antibody levels, INFγ production, PHA skin reaction, and TI and
CORT levels among treatment groups, were compared by one way ANOVA (MINITAB
Statistical Software, Minitab Inc, USA). Where the ANOVA F test was significant,
differences between the means were determined using the value of the Least Significant
Difference (LSD).
6.3 Results
6.3.1 Clinical signs and lesions
At no time after the challenge with IBV was there any statistically significant evidence that
the proportion of CORT treated birds showing clinical signs differed from the proportion of
non CORT-treated chickens (Figure 6.2).
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
D
ay
 1
D
ay
 3
D
ay
 5
D
ay
 7
D
ay
 9
D
ay
 1
1
D
ay
 1
3
D
ay
 1
5
D
ay
 1
7
D
ay
 1
9
Days post IBV challenge
C
li
n
ic
a
l
sc
o
re
(0
-3
)
Figure 6.2.Mean clinical score (0-3) of birds (n =10) under CORT treatment for two days
before challenge with IBV (▲), treated with CORT for 5 days before challenge with IBV (■),
and not treated with CORT but challenged with IBV (●)
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Birds in the three CORT treatment groups, developed a significantly higher proportion of
hepatic lesions (p<0.05) compared with the birds not treated with CORT but challenged with
IBV, however there were no differences among the different CORT treatment groups (Figure
6.3).
Figure 6.3. Liver with haemorrhages, found in bird under CORT treatment from 23 days of
age,
6.3.2 Body and spleen weights
At 50 days of age the birds under CORT treatment (treatments groups 1, 3 and 4) had
significantly lower relative spleen weights (p<0.01) compared with birds not treated with
CORT. The mean relative spleen weights of birds that started the CORT treatment at 23 days
of age was lower (p<0.05) than that of birds starting the CORT treatment at 26 days of age.
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Table 6.1. Body and spleen weights from birds untreated with CORT but challenged with
IBV (IBV), treated with CORT from day 23 but not challenged with IBV (CORT 23), treated
with CORT from day 26 of age and challenged with IBV (IBV+CORT 26) and birds treated
with CORT from day 23 and challenged with IBV (IBV+CORT 23)
Treatment Body Weight Spleen Weight
%
CORT 23 1380 0.77 0.055
CORT 23 1370 0.74 0.054
CORT 23 1340 0.8 0.059
CORT 23 1530 1.2 0.078
CORT 23 993 0.42 0.042
CORT 23 916 0.45 0.049
CORT 23 1452 0.98 0.067
CORT 23 1560 1.13 0.072
0.059
IBV+ CORT 26 1820 0.99 0.054
IBV+ CORT 26 1570 0.87 0.055
IBV+ CORT 26 1352 0.86 0.063
IBV+ CORT 26 1034 0.54 0.052
IBV+ CORT 26 1156 0.65 0.056
IBV+ CORT 26 1910 1.2 0.058
IBV+ CORT 26 970 0.98 0.1
IBV+ CORT 26 1030 0.97 0.094
0.06
IBV+ CORT 23 2080 1.01 0.048
IBV+ CORT 23 1988 0.89 0.044
IBV+ CORT 23 1307 0.84 0.06
IBV+ CORT 23 1216 0.69 0.056
IBV+ CORT 23 938 0.45 0.047
IBV+ CORT 23 1012 0.65 0.064
IBV+ CORT 23 1345 0.76 0.056
IBV+ CORT 23 969 0.53 0.054
0.053
IBV 2643 3.57 0.135
IBV 2534 3.2 0.126
IBV 2654 3.48 0.131
IBV 2175 3.17 0.145
IBV 2452 3.26 0.132
IBV 2320 3.05 0.131
IBV 2178 2.97 0.136
IBV 2453 3.03 0.123
0.132
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6.3.3 Tonic immobility and CORT levels
At 49 days of age there were no differences in TI indices between the four treatment groups.
At 28 days of age the birds that started the CORT treatment 5 days before challenge (23 days
of age) had a higher (p<0.01) mean plasma CORT concentration than the birds not treated
with CORT (treatment group 2). At 36 days of age birds treated with CORT (groups 1, 3 and
4) had higher (p<0.01) mean plasma CORT concentrations than the birds not treated with
CORT (group 2), but there were no differences among the CORT treated groups (groups 1, 3
and 4). At 43 days of age the birds that started CORT treatment at 23 days of age (5 days
before challenge) had a higher (p<0.01) mean plasma CORT concentration than the other
groups (groups 1, 2 and 4) (Figure 6.4).
Figure 6.4. Plasma CORT concentration in chickens following CORT treatment from 26 days
of age and challenged with IBV (▲), treated with CORT from 23 days of age and challenged
with IBV (■), treated with CORT from 23 days of age but not challenged with IBV (○) and
birds not treated with CORT but challenged with IBV (●)
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6.3.4 Humoral immune response
At 1 day of age the birds had high titres of maternally-derived antibodies against IBV, which
had declined to zero at 28 days when IBV was administered intranasally and SRBC was
injected. At 43 days of age (15 days post challenge) the birds challenged with IBV had similar
IBV titres irrespective of CORT treatment, but at 50 days age all groups had equivalent titres
(Figure 6.5). The fact that the control group seroconverted (asymptomatically) indicated a
cross contamination event had occurred between isolation rooms.
Figure 6.5. Antibody titre to IBV (ELISA) in chickens following CORT treatment from 26
days of age and challenged with IBV (▲), treated with CORT from 23 days of age and
challenged with IBV (■), treated with CORT from 23 days of age but not challenged with
IBV (○) and birds not treated with CORT but challenged with IBV (●)
By day 8 after injection with SRBC (36 days of age) the chickens treated with CORT from 23
days of age (5 days before challenge) had a higher (p<0.01) mean antibody titre than birds not
treated with CORT, which in turn developed a higher (p<0.05) humoral immune response
than the birds treated with CORT from 2 days before challenge (26 days of age). At 15 days
post challenge there were no significant differences between treatments (Figure 6.6).
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Figure 6.6. Haemagglutinin titre to SRBC measured in chickens treated with CORT from 2
days before injection with SRBC (at 28 days of age) (▲), treated with CORT from 5 days
before injection with SRBC (■), treated with CORT at 23 days of age but without injection
with SRBC (○) and birds not treated with CORT but with injection with SRBC (●)
Note: the variability of HA titres between experiments (chapters 5 and 6). This was due to a
different source of sheep red blood cells which varied with respect to their antigenicity.
6.3.5 Cell mediated immune response
At 36 days of age (8 days post challenge) the levels of INFγ released by splenic lymphocytes
after in vitro stimulation with IBV antigen were higher (p<0.05) in the group of birds that had
been exposed to CORT from 5 days before challenge (23 days of age) in comparison with the
birds exposed to CORT from two days before challenge (26 days of age). At 15 days post
challenge the birds not treated with CORT had higher INFγ levels (p<0.01) than the birds
treated with CORT irrespective of duration of treatment (Figure 6.7).
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Figure 6.7. Levels of interferon gamma released from spleen cells stimulated with IBV
antigen and measured by ELISA in chickens treated with CORT from two days before
challenge with IBV (▲), treated with CORT from 5 days before challenge with IBV (■),
treated with CORT at 23 days of age but not challenged with IBV (○) and not treated with
CORT but challenged with IBV (●)
The skin reaction produced by the intradermal injection of PHA (injected 24 hours previously
at 49 days of age) in the birds from the groups treated with CORT, either 2 or 5 days pre-
challenge, had smaller (p<0.001) reactions (right wattle) than birds infected with IBV but not
treated with CORT.
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Table 6.2. The skin reaction produced by the intradermal injection of PHA into the wattles of
the birds from groups treated with CORT 2 days pre-challenge with IBV (IBV+CORT 26), 5
days pre-challenge (IBV+CORT 23), and not treated with CORT (IBV).
Treatment
Left
Wattle
Right
Wattle Difference
IBV+CORT 23 4.69 11.28 2.4
IBV+CORT 23 5.1 10.71 2.1
IBV+CORT 23 2.28 8.59 3.76
IBV+CORT 23 1.92 8.09 4.21
IBV+CORT 23 1.86 8.08 4.34
IBV+CORT 23 2.87 9 3.13
IBV+CORT 23 3.3 9.7 2.93
IBV+CORT 23 3.24 10.08 3.11
3.24
IBV 1.9 10.98 5.77
IBV 1.92 12.67 6.59
IBV 1.09 5.09 4.66
IBV 1.41 7.6 5.39
IBV 1.27 4.34 3.41
IBV 1.27 5.33 4.19
IBV 2.08 10.2 4.9
IBV 2.1 11.09 5.2
5.01
IBV+CORT 26 2.05 7.34 3.58
IBV+CORT 26 2 3.2 1.6
IBV+CORT 26 1.69 4.55 2.69
IBV+CORT 26 1.77 5.53 3.12
IBV+CORT 26 3.05 6.22 2.03
IBV+CORT 26 1.69 5.63 3.3
IBV+CORT 26 1.72 4.62 2.68
IBV+CORT 26 1.65 4.44 2.69
2.71
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Table 6.3. Summary of the effects of CORT on the immune response of chickens treated with
CORT from 2 days before challenge with IBV and injection with SRBC (CORT 26 IBV),
treated with CORT from 5 days before challenge with IBV and injection with SRBC (CORT
23 IBV), treated with CORT at 23 days of age but without challenge with IBV or injection
with SRBC (CORT), and birds not treated with CORT but challenged with IBV and injected
with SRBC (IBV). Different letters indicate p<0.05.
CORT 23
IBV
CORT 26
IBV
IBV CORT
Hepatic lesions +++b +++b +a +++b
Humoral response SRBC
8 days post challenge +++c +a ++b
Humoral response SRBC
15 days post challenge ++a ++a ++a
Humoral response IBV
15 days post challenge +++a +++a +++a
Humoral response IBV
22 days post challenge +++a +++a +++a +++a
Cell mediate response IBV
(IFNγ) 8 days post challenge +++b ++ab ++a
Cell mediated response IBV
(IFNγ) 15 days post challenge +a +a ++b
Skin reaction PHA
24 hours post injection +a +a +++b
6.4 Discussion
It is clear from these results that the longer duration (5 days vs 2 days) of exposure to elevated
CORT levels in blood prior to the immune challenge caused an enhancement of the resultant
immune response. This is consistent with the view that corticosteroids can exert distinct,
seemingly paradoxical, effects on cytokine expression, cytokine receptor expression and
cytokine-regulated biological response (Wiegers and Reul 1998). The majority of the studies
on corticosteroids have focused on the immunosuppressive actions of these stress hormones.
It is paradoxical that organisms should have evolved mechanisms to suppress immune
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function at a time when an active immune response may be critical for survival (Dhabhar
2002). While on the one hand, stress is thought to suppress immunity and increase
susceptibility to infections and cancer (Baltrusch et al 1991), on the other hand it also
exacerbates autoimmune and inflammatory diseases (Mei-Tal et al 1970) although
glucocorticoids are administered clinically to treat these diseases (Schleimer et al 1989).
Keeping these issues in mind, and based on the earlier studies (Chapter 5), it was
hypothesized in this experiment that CORT may either enhance or suppress immune function
depending on the timing of the administration.
In birds where CORT has been administered only inhibitory immune effects have been
demonstrated (Dohms and Metz 1991; El-Leyhey et al 2003, Post et al 2003). In the previous
experiment (Chapter 5) it was found that the immune system of the birds responded in
different ways, depending of the duration of the CORT treatment (2 days before challenge vs
5 days before challenge). However, the pilot and main trial were carried out at different times.
In order to confirm these results CORT was administered over two different time intervals
prior to challenge with an infectious agent (IBV) in the current experiment. The tests used to
measure the immune response and the antigens were the same as used previously.
For the first time in poultry it has been shown in this trial that the time between the beginning
of the CORT treatment and the moment of the challenge is crucial (Barber et al 1993;
Wiegers et al 1994). Birds that started to drink CORT 5 days before injection with SRBC had
an enhancement of the humoral immune response in comparison with the birds that started the
treatment 3 days later (2 days before challenge) or the birds that were injected with SRBC but
not treated with CORT. Furthermore, the birds that began to drink CORT 5 days before the
challenge developed a higher cell mediated immune response as measured by the level of
INF-γ released by the splenic lymphocytes after in vitro stimulation with IBV, in comparison
99
with the birds exposed to CORT for two days before challenge. Both were transient effects,
apparent 1 week after challenge. In humans, exposure to cortisol (hydrocortisone sodium
succinate, 500 mg/500 ml 5% dextrose, given i.v. by volume control pump at a rate of 3
µg/kg/min) for up to a week before a challenge with endotoxin enhances TNF-ά and IL-6
levels, whereas cortisol at the time of or after endotoxin challenge suppresses the cytokine
response (Barber et al 1993). Hangalapura et al (2004a) reported that 7 days of cold stress,
which has been reported to increased plasma CORT concentration (Luger et al 2003; and see
chapter 4), significantly enhanced cellular immunity, whereas 2 days of cold stress treatment
had differential effects on the cellular immunity, depending on the line of birds and the time
of immunization. The present work indicates that this effect may be due to the direct effects
of CORT. The results of this current experiment do not support the support the hypothesis that
the immunological actions of the CORT are vested in the basal levels of CORT in blood at the
moment of challenge as the blood levels of CORT in those animals treated did not differ
significantly. Our data support the belief that a long pre-exposure to physiological levels of
exogenous CORT causes adaptation for example, down-regulation of glucocorticoid receptors
or alteration of their affinity (Armario et al 1994; Fleshner et al 1995). In an experiment
described by Post et al (2003) the immunopressive effects of exogenous CORT were due to
very high plasma CORT concentrations (30-35 ng/ml), in comparison to the levels reached in
this experiment (9.5 ng/ml). The alterations in the CORT receptors are suggested because
removal of CORT via adrenalectomy increases corticosteroid binding globulin (CBG) levels.
CBG is a plasma carrier protein important for transporting CORT in a biologically inactive
form. CORT that is bound to CBG can not reach many target tissues and can not bind with
target receptors (Pardridge 1981). A reduction in the CBG would be expected to produce a
measurable increase in unbound or free biologically active CORT (Mendel 1989). The CORT
assay used in this experiment measured total CORT so it was not possible to estimate the
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amount of free CORT in the plasma. Enhancement of the immune response may occur via an
increase in receptor expression on several cell types (e.g., T cells) for IL-1 (Akahoshi et al
1988), IL-2 (Fernandez-Ruiz et al 1989), IL-4 (Paterson et al 1994), IL-6 (Campos et al 1993)
and IFN-γ (Strickland et al 1986). Furthermore, CORT administration induces a reduction of
blood leukocyte numbers, which reflects leukocyte redistribution from the blood to organs
such as the skin, mucosal lining of gastro-intestinal and urinary-genital tracts, lung, liver, and
lymph organs (e.g., spleen) where immunosurveillance occurs due to innate and acquired
immune mechanisms (Dhabhar 2002). Mechanisms involving leukocyte activation are also
enhanced during some stress situations; macrophage phagocytic activity (Lyte et al 1990)
would enhance innate immunity whereas increased macrophage antigen presentation (Sadeghi
et al 1992) would enhance adaptive immunity.
The skin reaction against PHA injected 24 hours previously (day 49 of age) showed that the
birds from the groups treated with CORT either 2 or 5 days pre-challenge had significantly
smaller reactions in agreement with our previous studies. This process (skin reaction against
PHA) involves a variety of cells such as macrophages, basophils, heterophils, B lymphocytes
and cytokines secreted by the local T lymphocytes (Stadecker et al 1977). It is an in vivo test
that provides a general index of non-specific cell mediated immunity (Tella et al 2002). The
other test used in this experiment was an in vitro, antigen-specific (IBV) assay that reflects the
production of INFγ from T cells present in the spleen that had been previously sensitized
(Lambrecht et al 2000). In order to try and elucidate if the lesions in the different tissues were
caused by the use of CORT or by IBV, a group of birds were kept isolated from the pathogen
(treatment group 1). However by the end of the experiment a contamination event involving
IBV had occurred via the ventilation system and the control birds developed antibodies
(Figure 6.3) indicating an inadvertent infection had occurred. The birds under CORT
treatment developed a significantly higher proportion of hepatic lesions in comparison with
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those not treated with CORT irrespective of IBV infection in accordance with previous
reports (Saadoun et al 1987; Puvadolpirod and Thaxon 2000; Post et al 2003). The
administration of CORT caused splenic atrophy in agreement with Dohms and Metz (1991)
and Post et al (2003) and in parallel with the dramatic decrease in INF γ production from
spleen cells, 15 days post challenge.
In this study the duration of the tonic immobility did not show significant difference between
groups in contrast to the previous experiment (Chapter 5). This response, triggered by
physical restraint and characterised by a catatonic-like state of reduced responsiveness, shows
large variability between animals and sometimes the results do not agree with other tests
(Campo et al 2005) used for measuring animal welfare.
In summary, duration of CORT treatment affects immune outcome. It is not clear whether
this is due to temporal effects per se or cumulative dose at the time of antigen challenge. It is
unknown whether this transient period of immmunoenhancement gives benefits to birds as
they adjust homeostatically to their environmental stressors.
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Chapter 7
GENERAL DISCUSSION
The poultry industry in New Zealand holds an enviable sanitary status. Major pathogens such
as infectious bursal disease virus, chicken anaemia virus and Newcastle disease virus are
absent or if present, show a mild pathogenicity or are controlled by limited breeder
vaccination. This status can be attributed to progressive biosecurity legislation and practices
and the fact that the majority of the poultry industry is controlled by a small number of
companies, who use well-designed, rational, vaccinal and therapeutic programmes. Despite
the improvements in health and management, diseases such as infectious bronchitis are still
putting the sanitary status of poultry flocks in serious risk. In New Zealand, as in many
countries, IB shows distinct winter seasonality, despite the flocks being housed in controlled
environment sheds. New Zealand, as well as many other developed countries is experiencing
a tendency for consumers to want to return to more ‘natural’ husbandry systems for rearing
poultry, such as free range chickens. Under this production system, which has few restricting
criteria, the birds may face many stressors such as extreme ambient temperatures that can
jeopardize their homeostasis and, so, affect their welfare. In New Zealand the free range
concept is typically more limited with options to go outside and usually only after 3 weeks of
age.
The first experiment described in this thesis was a case control study (Chapter 3), to
determine the prevalence of IBV in broilers within the Canterbury province of New Zealand
in late winter and spring and to assess whether a particular management practices or
environmental factors (risk factors) were related to the presence of IBV. It was found that
there was a high (50%) prevalence of IBV, as detected by RT-PCR, in the farms visited in
Canterbury, but under the conditions of management in these large commercial units (e.g.,
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temperature, inter-current infections, etc), the virus caused mild disease. Environmental
changes are the explanation most often used to explain the seasonality of infectious diseases.
In this experiment, it was found that relative humidity within the sheds had an inverse
relationship (p=0.05; Odds Ratio=0.92) to the presence of the virus, which means that high
humidity is unfavourable for the presence or establishment of the virus in the cloaca and
trachea. It has been proposed that the drying of mucosal surfaces increases the probability of
colonization by microorganisms (Dowell 2001). With airborne human coronaviruses it has
been reported that high relative humidity is less favourable to its survival than low humidity
(Ijaz et al 1985).
With a possible change to ‘free range’ management systems one question that arises is, what
changes in IB status could occur in New Zealand? It was assumed that extremes (high or low)
of ambient temperature would be one of the principal stress situations that the fast growing
broilers will face in a “free range” situation and for that reason this stress factor was initially
studied.
Previous studies on the effect of temperature on the immune system in birds had showed
inconsistent results. Some studies reported that an extreme temperature (high or low) can
produce immunosupression but other studies have shown an enhancement of the immune
response. The variability between results can be attributed, in part, to the specific
immunologic parameters measured, assay techniques and the different breeds of chickens
used in the different experiments. In the first experiment to be conducted (Chapter 4), 3
different temperature regimes were chosen bracketing the temperature that the birds could
face under field conditions: either high (30 +/- 2
o
C), or moderate (20 +/- 2
o
C) or low (10 +/-
2
o
C), with relative humidity levels of 45-55%. Following infection with IBV, it was found
that low temperatures caused an exacerbation of the IBV-like respiratory signs and that high
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temperatures caused hepatic lesions. Given the ubiquitous presence of IBV in many poultry
sheds the implications for such temperature changes are clear. It is not known what effect
short – term temperature fluctuations of the same magnitude (+/- 10
o
C) would have.
By thirteen days after IBV challenge (35 days of age), the mean antibody titre for IBV was
lower in birds housed under high (p<0.05) temperature compared to the moderate temperature
and there was a tendency to have lower antibody levels to IBV in birds housed under the low
temperature. The immunosuppressive effects of stress have been hypothesized to be via the
production of glucocorticoids, and in this experiment a link between low (but not high)
temperature and CORT levels in plasma (8, 15, and 22 days post challenge) was found.
Several researchers have demonstrated that stress-induced suppression of immunity can be
produced in an adrenal-independent manner, suggesting that a variety of other hormones,
neurosecretory products and cytokines may also be involved (Bonneau et al 1993; Keller et al
1983). It has been reported that heat stress decreases the release of T-helper 2 cytokines, that
are important for antibody production (Lebman and Coffman 1998), and that heat stress in
chickens also stimulates free oxygen radical production, which is known to have several non-
specific damaging effects on the immune system (Mujahid et al 2005). Possibly, the
requirement of nutrients required to maintain an efficient immune response were not met in
the current experiment due to a reduction in feed intake plus low feed digestibility (proteins,
fat, starch), and this became evident when the birds are under heat stress (Bonnet et al 1997).
Interestingly, the humoral response to the other antigen used (SRBC) was reversed; that is
enhancement in the birds housed at high temperature. This enhanced response was similar to
observations made by Heller et al (1979) and Regnier et al (1980) following short periods of
elevated temperatures and using the same antigen (SRBC). The difference in the humoral
immune response to IBV and to SRBC may simply be a reflection of the antibody isotype
(IgG vs IgM) detected by the different assays used or it could indicate fundamental
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differences in immunity to these antigens. These differences could relate to type of
preparation (particulate; small versus large RBC), route of administration (injection vs
intranasal) and the presence of inflammation with the IBV challenge. Either way the findings
should hint at being cautious when using the terms immunosuppression or enhancement.
The other physiological parameters studied such as body weight, haematocrit, and tonic
immobility showed that the birds under extreme temperatures (high or low) had to make
substantial physiological adjustments in order to return to homeostasis. These adjustments can
jeopardize their welfare.
From the time chicks are hatched, throughout their lives, different stressors confront them and
threaten their welfare. The physiological regulation of homeostasis is attained by complex
endocrine interactions, principally by the hormones secreted from the adrenal gland (Harvey
et al 1984). Corticosterone (CORT) is the principal glucocorticoid released by adrenal glands
in birds in response to hypothalamic-pituitary activity (Harvey et al 1984). Current concepts
on the role of CORT in the regulation of inflammatory and immune response depict its role as
being inhibitory. Surprisingly, CORT has been shown to up regulate the expression of various
cytokine receptors and express synergism with several cytokines, which is in apparent
contrast to the other ‘restraining’ effects of this hormone (Wiegers and Reul 1998). The trial
described in Chapter 5 sought to assess the effects of the stress on the immune system by the
use of exogenous CORT in the drinking water in an attempt to produce levels of CORT in the
blood that would be similar to those found in stress situations. An initial pilot trial was carried
out in order to assess the correct amount of CORT to administer via the drinking water for the
principal trial. For logistic reasons the time between when the birds started to drink CORT
and the time of the IBV challenge, was not the same for both trials (the pilot trial and the main
trial). In the pilot trial, when the birds were challenged 2 days after the start of the CORT
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treatment, immunosuppression of humoral immunity occurred, in contrast to enhancement of
the immune response in the main trial, where the birds were challenged 5 days after the start
of the CORT treatment. Because these contradictory results could have been a reflection of
different management factors at the different trial times an additional experiment was carried
out (Chapter 6). In this experiment IBV infections occurred at 2 or 5 days after the beginning
of the CORT treatment. It was found that the time between the CORT treatment and challenge
was crucial for determining the immune response (enhancement or suppression), as it is in
humans (Barber et al 1993) and rats (Wiegers et al 1994). The birds that started to drink
CORT 5 days before being injected with SRBC and challenged with IBV showed an
enhancement in the humoral and cellular immune response in comparison to the birds that
started the treatment 3 days latter (2 days before challenge). The reasons for this are unknown,
but it is understood that the immune actions of the CORT are rooted in the basal levels of
plasma CORT at the moment of challenge. In this experiment the levels of CORT in the
plasma from the 5 day CORT-treated birds, were similar at the time of challenge to the 2 day
CORT-treated birds. Therefore, either the period of CORT treatment or the cumulative dose
has led to immunoenhancement at least for a short period of time (1-13 days). The pre-
exposure to high levels of exogenous CORT caused down-regulation of receptors of
corticosteroid-binding globulin (CBG) or affinity (Armario et al 1994; Fleshner et al 1995).
CBG is a plasma carrier protein important for transporting CORT in its biologically inactive
form in which state it can not bind with target receptors (Pardridge 1981). A reduction in
CBG reactivity would be expected to produce a measurable increase in unbound or free
biologically active CORT (Mendel 1989). Free CORT was not measured in these
experiments. Spencer and McEwen (1990), showed that frequent exposure to a chronic stress
can decrease the neuroendocrine response, in contrast to these findings, but this may reflect
the longer period of their study compared to the present research.
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These findings emphasize the dynamic nature of CORT production following the imposition
of stressors, which may, or may not, cause measurable changes in serum CORT levels. Hence
‘one off’ CORT assays may not accurately determine welfare status of poultry. Short term
peaks of exogenous CORT may be detrimental and more sustained elevated levels beneficial
to aspects of the immune response. Over all, these beneficial effects are short term and of
uncertain value homeostatically, except for example where they may interfere with the
success of a vaccination program.
The studies described in this thesis have attempted to clarify the effects of stress on the
immune system of the broiler chickens, but future experiments should be designed in order to
broaden the results found in this study. Several important issues remain to be addressed. The
first study described in this thesis (Chapter 3) determined the prevalence of IBV and whether
particular management or environmental factors weres related to its presence. If the wish of
the chicken broiler industry is to produce ‘free range’ chickens, additional epidemiological
studies should be pursued with careful choice of controls. Other risk factors, such as day
length (number of hours of light per day) should be investigated as part of a production
system. In the short days and long nights of winter, more melatonin is secreted than in the
longer days of summer (Lam et al 2004). Several studies have demonstrated that melatonin
markedly enhances macrophage activity, elevates antibody response, increases cytokine
production from macrophages and T helper 1 lymphocytes (e.g., IFNγ) and produces
reproductive and behaviour changes (Nelson and Demas 1997; Liu et al 2001).
In the second experiment described in this thesis (Chapter 4), it was found that the birds
housed at high temperature developed a lower humoral immune response to IBV but there
was no link with corticosterone levels. It would be interesting to measure the effect of high
temperature on other homeostatic hormones such as the catecholamines. Certain studies have
reported that elevated levels of norepinephrine, and epinephrine can induce
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immunosuppression (Pedersen and Hoffman-Goetz, 2000). The use of a non-selective β-
adrenergic antagonist (β blocker) would help to determine if the immunomodulatory effects
(depression or enhancement) of heat stress are mediated by the activation of β-adrenergic
receptors via catecholamines. Certain immune parameters were not examinated in these
studies, for example local antbody (IgA) production and alterations to innate immune
mechanisms, such as ά and β IFN. Some studies on the levels of T-helper 2 cytokines (e.g.,
IL6, IL8, IL2) could be made in order to clarify if there is any alteration in the release of those
cytokines as a result of heat stress, as has been reported in rats (Wang et al 2001). Also, the
phagocytic activity of blood leukocytes should be assessed, since it has been reported that
high temperature reduces phagocytic activity of blood leukocytes in birds (Kadymov and
Aleskerov 1988) and CORT has been reported to enhance it (Lyte et al 1990).
In conclusion, the effects of stress on these immune parameters are complex, and their
relationship to the intensity or duration of the stressor is not clear, as reported by Pruett
(2001). The experiments described in Chapters 4, 5 and 6 indicate that stress and the
administration of CORT can exert immunoenhancing and immunosuppressive effects under
differing conditions. It has been suggested that a stress-induced suppression of immune
function may be evolutionarily adaptive because immunosuppression may conserve the
energy that is required to deal with the immediate demands imposed by a stressor. However,
immunosuppression does not necessarily conserve energy and some of the proposed
mechanisms for immunosuppression, such as apoptosis of leukocytes, are likely to expend
energy (Dhabhar 2002). Moreover, the immune system may often be critically needed for
providing an immediate response to the actions of the stress-inducing agent (e.g., wounding
by a predator). Furthermore, the time course for many proposed mechanisms for stress-
induced immunosuppression, such as inhibition of prostaglandin synthesis, cytokine
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production, or leukocyte proliferation (Schleimer et al 1989) is significantly longer than that
seen during acute stress (Dhabhar 2002).
Environmental stressors such as low or high temperature do affect the physiology of the fast
growing broiler. The adjustments that birds have to make to maintain homeostasis change the
course of common infectious diseases, such as IB, that under optimal conditions commonly
present in the New Zealand poultry industry, manifests itself as a mild disease.
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Appendix I
QUESTIONAIRE: INFECTIOUS BRONCHITIS
(DELETE INCORRECT ANSWER OR ADD THE CORRECT ANSWER)
ACCESSION NUMBER (lab use)………
1. FARM NAME…………………………….SHED NUMBER (or name)………
2. NAME OF FRAMMANAGER……………………
3. DATE……………………
4. LOCATION ADDRESS……………………………………………PHONE………
5. NUMBER OF SHEDS ON FARM…………
6. OPEN-SIDE OR CONTROLLED ENVIRONMENTAL SHED
7. ALL-IN, ALL-OUT SYSTEM? YES/NO
8. DENSITY OF BIRDS IN THE SHED…………..(BIRDS PER SQUARE
METRE)
9. 9 BREED………………..
10. AGE…………
11. TYPE OF OPERATION (FLOOR, CAGE, FREE RANGE ETC)……………….
12. FEEDING PROGRAMME (RESTRICTED OR OPEN ACCESS) IF IT IS
RESTRICTED EXPLAIN HOW
13. LEVEL OF PROTEIN IN FEED (%)……………
14. FEED PRESENTATION (PELLETS, CRUMBLES, ETC)
15. FEED CONVERSION RATIO (CURRENTLY)…………………….
16. WATER ACCESS (RESTRICTED OR OPEN ACCESS)………………………
17. WATER CONSUMPTION (PER 1000 BIRDS)………………………
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18. MEAN SHED TEMPERATURE (DAY TIME)………….(NIGHT TIME)………..
19. VENTILATION PROGRAM INWINTER
20. WETNESS OF LITTER: Pick up a handful of litter and squeeze it tightly. When you
open your hand: (A) a cohesive ball was formed or (B) crevices are formed in the
compressed material or (C) the litter fell away in a pile (DELETE THE
INCORRECT ONE)
21. TYPE OF LITTER (DESCRIBE TYPE)…………..NEW OR USED
22. FLOOR (SOIL OR CONCRETE)………………………….
23. PROGRAMME OF LIGHTING…………………………..
24. IS THE SHED EMPTIED, CLEANED, DISINFECTED, AND READIED
BETWEEN BATCHES OF CHICKS (YES/NO)………….. IF YES TO
PREVIOUS QUESTION, WHAT IS THE TIME PERIOD FOLLOWING THIS
PROCEDURE TILL RE-STOCKING (IN DAYS)…2 weeks………..
25. VACCINATION PROGRAMME (I.B OR OTHERS)
26. DATE ILLNESS FIRST SEEN………………..
27. SIGNS OF SICKNESS…………..
28. NUMBER OF DEAD BIRDS PER DAY……………….
29. DISTANCE BETWEEN THIS SHED AND ITS CLOSEST NEIGHBOURING
SHED…………..
30. HYGIENE MEASUES USED BY PERSONNEL WHENMOVING TO AND
FROM OTHER SHEDS…………………….
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Appendix II
Mean of certain ambient parameters
Farm
Temp Oxygen
%
Ammonia
ppm
Carbon
dioxide
%
Relative
humidity
%
Litter
humidity
(1-4) RT-PCRCº
1 Case 21 20.1 20 0 89 2 negative
1 Control 21 20.3 20 0.2 97 3 negative
2 Case 21 20.3 30 0.5 70 3.5 trachea +
2 Control 20 20.5 20 0.2 70 3.5 negative
3 Case 20 20.1 20 0.7 92 3.5 negative
3 Control 20 20 20 0.8 92 3.5 negative
4 Case 22.5 20.9 18 0.1 75 1 negative
4 Control 22.5 20.5 16 0.1 65.5 1 negative
5 Case 21 20.3 15 0.1 60 3.5 cloaca +
5 Control 21.5 20.5 15 0.2 58 2 negative
6 Case 29 20.1 35 0.64 90 2 cloaca +
6 Control 28.9 20.4 5 0.48 77 2 negative
7 Case 24 20.3 7 0.15 60 3.5 tra-cloa+
7 Control 22 20.9 7 0.13 58 3 negative
8 Case 28 20.6 40 0.4 93 3 negative
8 Control 27.8 20.5 50 0.41 94 3 negative
9 Case 20 20.4 18 0.2 50 3.5 tra-cloa+
9 Control 20 20.5 18 0.2 53 3.5 tra-cloa+
10 Case 20 20.6 5 0.3 88 1 negative
10 Control 20 20.4 7 0.4 75 1 negative
Required sample size for different flock sizes, prevalences and test sensitivities to obtain
a 95% certainty to detect an infection (Canon and Roe (1982)
Flock size Expected test
sensitivity
Prevalence %
50-100
Prevalence %
25
Prevalence %
10
10000 100 2 11 29
50 4 22 58
25 8 44 116
100000 100 2 11 29
50 4 22 58
25 8 44 116
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Appendix III
Number of animals with specific clinical signs scores 0-3
Clinical signs birds high temperature day 1 day 2 day 3 day 4 day 5 day 6
no clinical signs (0) 20 17 15 12 12 8
lacrimation, slight heat movement sneezing, coughing (1) 3 4 8 4 6
lacrimation, tracheal rales, nasal exudates, depression (2) 1 4
same as 2 but stronger, plus swollen heads (3)
 
Clinical signs birds high temperature day 8 day 9 day 10 day 11 day 12 day 13  
no clinical signs (0) 9 8 6 8 10 7
lacrimation, slight heat movement sneezing, coughing (1) 4 6 6 6 4 1
lacrimation, tracheal rales, nasal exudates, depression (2) 1 2
same as 2 but stronger, plus swollen heads (3)
 
Clinical signs birds high temperature day 15 day 16 day 17 day 18 day 19 day 20  
no clinical signs (0) 8 8 8 8 8 8
lacrimation, slight heat movement sneezing, coughing (1) 0 0 0 0 0 0
lacrimation, tracheal rales, nasal exudates, depression (2)
same as 2 but stronger, plus swollen heads (3)
 
Clinical signs birds low temperature day 1 day 2 day 3 day 4 day 5 day 6
no clinical signs (0) 20 17 7 2 1 1
lacrimation, slight heat movement sneezing, coughing (1) 3 6 8 9 8
lacrimation, tracheal rales, nasal exudates, depression (2) 7 10 4 5
same as 2 but stronger, plus swollen heads (3)
 
Clinical signs birds low temperature day 8 day 9 day 10 day 11 day 12 day 13  
no clinical signs (0) 2 3 3 3 4 5
lacrimation, slight heat movement sneezing, coughing (1) 8 9 9 9 9 0
lacrimation, tracheal rales, nasal exudates, depression (2) 4 2 2 2 1 3
same as 2 but stronger, plus swollen heads (3)
 
Clinical signs birds low temperature day 15 day 16 day 17 day 18 day 19 day 20
no clinical signs (0) 6 6 6 7 7 7
lacrimation, slight heat movement sneezing, coughing (1) 0 0 1 1 1 1
lacrimation, tracheal rales, nasal exudates, depression (2) 2 2 1
same as 2 but stronger, plus swollen heads (3)
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Clinical signs birds moderate temperature day 1 day 2 day 3 day 4 day 5 day 6
no clinical signs (0) 20 20 18 14 13 8
lacrimation, slight heat movement sneezing, coughing (1) 2 6 5 4
lacrimation, tracheal rales, nasal exudates, depression (2) 2 2
same as 2 but stronger, plus swollen heads (3)
Clinical signs birds moderate temperature day 8 day 9 day 10 day 11 day 12 day 13
no clinical signs (0) 10 9 10 10 10 8
lacrimation, slight heat movement sneezing, coughing (1) 3 4 4 4 4 0
lacrimation, tracheal rales, nasal exudates, depression (2) 1 1
same as 2 but stronger, plus swollen heads (3)
Clinical signs birds moderate temperature day 15 day 16 day 17 day 18 day 19 day 20
no clinical signs (0) 8 8 8 8 8 8
lacrimation, slight heat movement sneezing, coughing (1) 0 0 0 0 0 0
lacrimation, tracheal rales, nasal exudates, depression (2)
same as 2 but stronger, plus swollen heads (3)
Clinical score of the three treatment groups over time
High Moderate Low
Day 1 0 0 0
Day 2 0.15 0 0.15
Day 3 0.3 0.1 1
Day 4 0.4 0.3 1.4
Day 5 0.6 0.45 1.2
Day 6 0.4 0.4 1.28
Day 7 0.42 0.42 1.21
Day 8 0.42 0.35 1.1
Day 9 0.42 0.42 0.9
Day 10 0.71 0.28 0.9
Day 11 0.42 0.28 0.9
Day 12 0.28 0.28 0.78
Day 13 0.12 0 0.75
Day 14 0.12 0 0.5
Day 15 0 0 0.5
Day 16 0 0 0.5
Day 17 0 0 0.37
Day 18 0 0 0.12
Day 19 0 0 0.12
Day 20 0 0 0.12
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Appendix IV: Number of animals with specific lesion scores (0-3)
       
         
    LESIONS    
         
  High     High  
Air sac Day 6p.i Day 13 p.i Day 20 p.i Heart Day 6p.i Day 13 p.i Day 20 p.i
scored 0 3 5 6 scored 0 6 6 6
scored 1 3 1 scored 1
scored 2 scored 2
scored 3 scored 3
High High
Liver Day 6p.i Day 13 p.i Day 20 p.i Kidney Day 6p.i Day 13 p.i Day 20 p.i
scored 0 6 1 4 scored 0 6 6 6
scored 1 0 2 scored 1
scored 2 5 scored 2
scored 3 scored 3
         
High       
Trachea Day 6p.i Day 13 p.i Day 20 p.i      
scored 0 4 5 6      
scored 1 2 1       
scored 2       
scored 3       
      
Moderate   Moderate
Air sac Day 6p.i Day 13 p.i Day 20 p.i  Heart Day 6p.i Day 13 p.i Day 20 p.i
scored 0 5 6 6  scored 0 6 6 6
scored 1 1   scored 1
scored 2   scored 2
scored 3   scored 3
  
  
Moderate   Moderate
Liver Day 6p.i Day 13 p.i Day 20 p.i  Kidney Day 6p.i Day 13 p.i Day 20 p.i
scored 0 6 6 6  scored 0 6 6 6
scored 1   scored 1
scored 2   scored 2
scored 3   scored 3
      
Moderate       
Trachea Day 6p.i Day 13 p.i Day 20 p.i      
scored 0 5 6 6      
scored 1 1       
scored 2       
      
Low   Low
Air sac Day 6p.i Day 13 p.i Day 20 p.i  Heart Day 6p.i Day 13 p.i Day 20 p.i
scored 0 6 6  scored 0 3 1 5
scored 1 6   scored 1 2 2
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scored 2   scored 2
scored 3   scored 3 1 3 1
      
Low   Low
Liver Day 6p.i Day 13 p.i Day 20 p.i  Kidney Day 6p.i Day 13 p.i Day 20 p.i
scored 0 4 3 3  scored 0 4 4 6
scored 1 2 3 3  scored 1 2 2
scored 2   scored 2
scored 3   scored 3
      
Low       
Trachea Day 6p.i Day 13 p.i Day 20 p.i      
scored 0 2 5 6      
scored 1 3 1       
scored 2 1       
scored 3       
Composite lesion score (mean) in each treatment group
Lesions found in birds 6 days after challenge
Tracheal
lesions
Air sac
lesions
Heart
lesions
Liver
lesions
Kidney
lesions
High 0.33 0.5 0 0 0
Moderate 0.16 0.16 0 0 0
Low 0.83 1 0.83 0.33 0.33
Lesions found in birds 13 days post challenge
Tracheal
lesions
Air sac
lesions
Heart
lesions
Liver
lesions
Kidney
lesions
High 0.16 0.33 0 1.66 0 
Moderate
0 0 0 0 0 
Low 0 0 1.8 0.5 0.33 
Lesions found in birds 20 days post challenge
Tracheal
lesions
Air sac
lesions
Heart
lesions
Liver
lesions
Kidney
lesions
High 0 0 0 0.33 0
Moderate 0 0 0 0 0
Low 0 0 0.5 0.5 0
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Appendix V
Spleen and body weights (% = spleen/body weights)
Body
weight
grams
Spleen
weight
grams
%
Bird 1 (control) 2089 1.7 0.08
Bird 2 (control) 2028 1.5 0.07
Bird 3 (control) 1705 1.4 0.08
Bird 4 (control) 1962 1.8 0.09
Bird 5 (control) 1827 2.2 0.12
Bird 6 (control) 2054 1.6 0.07
Bird 1 (IBV SRBC) 1709 1.5 0.08
Bird 2 (IBV SRBC) 1802 1.7 0.09
Bird 3 (IBV SRBC) 1819 1.6 0.08
Bird 4 (IBV SRBC) 1715 1.5 0.08
Bird 5 (IBV SRBC) 1867 1.8 0.09
Bird 6 (IBV SRBC) 1717 1.5 0.08
Bird 1 (IBV SRBC
Cort)
1064 0.3 0.028
Bird 2 (IBV SRBC
Cort)
1066 0.4 0.037
Bird 3 (IBV SRBC
Cort)
1458 1 0.068
Bird 4 (IBV SRBC
Cort)
1256 0.5 0.039
Bird 5 (IBV SRBC
Cort)
1496 1.2 0.08
Bird 6 (IBV SRBC
Cort)
1302 0.9 0.069
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Appendix VI
Solutions for INF γ test
SOLUTION FORMULATION
Coating Buffer 8.0 g NaCl
1.42 g Na2HPO42H2O
0.2 g KH2PO4
0.2 g KCl
q.s. to 1 litre with distilled H2O, pH 7.4
Blocking Solution 8.0 g NaCl
1.42 g Na2HPO42H2O
0.2 g KH2PO4
0.2 g KCL
5.0 g bovine serum albumin (fraction V)
q.s. to 1 litre with distilled H2O, pH 7.4
Wash Buffer 9.0 g NaCl
1 mL Tween 20
q.s. to 1 litre with distilled H2O, pH 7.4
Stop Solution 1.8 NH2SO4
